,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.012399870620181,0,0,19934.0,113899.85357353876,CEBPA
1,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.012399870620181,0,0,19851.0,97261.02051561224,CEBPA
2,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.012399870620181,0,0,19814.0,92684.96451050608,CEBPA
3,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CEBPA
4,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0035249384088572,0,0,19955.0,121662.49782449217,CCNH
5,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0035249384088572,0,0,19953.0,120782.64067395544,CCNH
6,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,CCNH
7,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,RAD21
8,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,SETD2
9,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,DNMT3A
10,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,DNMT3A
11,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR8H2
12,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,ARID1A
13,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,ARID1A
14,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0105998955026255,0,0,19877.0,101200.07933676826,AP1M1
15,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,AP1M1
16,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0149997992131669,0,0,19931.0,112996.7391397682,PTGER2
17,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0149997992131669,0,0,19900.0,105436.78197328727,PTGER2
18,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0168748379685508,0,0,19788.0,89974.27756224656,PTGER2
19,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0168748379685508,0,0,19775.0,88738.27077557483,PTGER2
20,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0202798389918715,0,0,19662.0,80229.79996326564,PTGER2
21,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PTGER2
22,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0106998604053851,0,0,19934.0,113899.85357353876,RUNX1
23,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0106998604053851,0,0,19924.0,111031.8499691117,RUNX1
24,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0106998604053851,0,0,19893.0,104053.753408911,RUNX1
25,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0111598835581629,0,0,19830.0,94543.49009679438,RUNX1
26,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0111598835581629,0,0,19814.0,92684.96451050608,RUNX1
27,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,RUNX1
28,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0109598702076242,0,0,19926.0,111574.38983110404,CBL
29,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0109598702076242,0,0,19924.0,111031.8499691117,CBL
30,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0109598702076242,0,0,19915.0,108752.83801948265,CBL
31,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0109598702076242,0,0,19863.0,98987.62735269018,CBL
32,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0109598702076242,0,0,19863.0,98987.62735269018,CBL
33,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0133998647837319,0,0,19799.0,91079.21596609056,CBL
34,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0139427280593492,0,0,19756.0,87051.4275316661,CBL
35,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CBL
36,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,WT1
37,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0139362282047116,0,0,19928.0,112131.59838572376,CCND3
38,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0139362282047116,0,0,19876.0,101034.04709010696,CCND3
39,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0139362282047116,0,0,19862.0,98838.19160389496,CCND3
40,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0139362282047116,0,0,19842.0,96053.2110949472,CCND3
41,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0139362282047116,0,0,19840.0,95793.96509856998,CCND3
42,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0139362282047116,0,0,19840.0,95793.96509856998,CCND3
43,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0139362282047116,0,0,19838.0,95537.86936302872,CCND3
44,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0139362282047116,0,0,19801.0,91286.4288690606,CCND3
45,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0139362282047116,0,0,19799.0,91079.21596609056,CCND3
46,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0139362282047116,0,0,19799.0,91079.21596609056,CCND3
47,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0139362282047116,0,0,19781.0,89299.85161916987,CCND3
48,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0190613905368566,0,0,19670.0,80733.60565076157,CCND3
49,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0190613905368566,0,0,19646.0,79255.8617626126,CCND3
50,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CCND3
51,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH10
52,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,ETV6
53,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,STAG2
54,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,U2AF2
55,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0129331582145885,0,0,19935.0,114209.92613860144,FLT3
56,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0129331582145885,0,0,19934.0,113899.85357353876,FLT3
57,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0129331582145885,0,0,19903.0,106058.9096435903,FLT3
58,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0185598242159366,0,0,19814.0,92684.96451050608,FLT3
59,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0185598242159366,0,0,19768.0,88101.22480150245,FLT3
60,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0196664999382009,0,0,19705.0,83086.53988020132,FLT3
61,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0202284144472764,0,0,19646.0,79255.8617626126,FLT3
62,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FLT3
63,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.005699906652596,0,0,19943.0,116875.00742975442,AK9
64,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,AK9
65,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0164998189106955,0,0,19835.0,95159.46482222488,BCAP31
66,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,BCAP31
67,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,NSD1
68,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,SNX32
69,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0084999078692823,0,0,19840.0,95793.96509856998,AMOT
70,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,AMOT
71,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0133998398995484,0,0,19866.0,99442.43560916925,SRSF2
72,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SRSF2
73,KEGG_2019_Human,Intestinal immune network for IgA production,1/48,0.0023999583567988,0.0102665548346894,0,0,19952.0,120356.5272753826,TGFB1
74,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0102665548346894,0,0,19951.0,119939.1172087114,TGFB1
75,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0102665548346894,0,0,19935.0,114209.92613860144,TGFB1
76,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0102665548346894,0,0,19931.0,112996.7391397682,TGFB1
77,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0102665548346894,0,0,19926.0,111574.38983110404,TGFB1
78,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0102665548346894,0,0,19925.0,111301.33528642564,TGFB1
79,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0102665548346894,0,0,19924.0,111031.8499691117,TGFB1
80,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0102665548346894,0,0,19915.0,108752.83801948265,TGFB1
81,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0102665548346894,0,0,19914.0,108514.46102290176,TGFB1
82,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0102665548346894,0,0,19910.0,107587.50385474482,TGFB1
83,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0102665548346894,0,0,19909.0,107362.10783923086,TGFB1
84,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0102665548346894,0,0,19909.0,107362.10783923086,TGFB1
85,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0102665548346894,0,0,19904.0,106270.50039849174,TGFB1
86,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0102665548346894,0,0,19900.0,105436.78197328727,TGFB1
87,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0102665548346894,0,0,19897.0,104832.7525292024,TGFB1
88,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0102665548346894,0,0,19893.0,104053.753408911,TGFB1
89,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0102665548346894,0,0,19887.0,102937.34947211576,TGFB1
90,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0102665548346894,0,0,19876.0,101034.04709010696,TGFB1
91,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0102665548346894,0,0,19873.0,100543.72072014232,TGFB1
92,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0102665548346894,0,0,19870.0,100064.62842845908,TGFB1
93,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0102665548346894,0,0,19868.0,99751.22090491928,TGFB1
94,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0102665548346894,0,0,19851.0,97261.02051561224,TGFB1
95,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0102665548346894,0,0,19851.0,97261.02051561224,TGFB1
96,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0102665548346894,0,0,19840.0,95793.96509856998,TGFB1
97,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0102665548346894,0,0,19840.0,95793.96509856998,TGFB1
98,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0102665548346894,0,0,19837.0,95410.9786681514,TGFB1
99,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0102665548346894,0,0,19832.0,94787.72752807094,TGFB1
100,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0105481024157804,0,0,19821.0,93478.0629355712,TGFB1
101,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0114360914964609,0,0,19799.0,91079.21596609056,TGFB1
102,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0120448829483578,0,0,19781.0,89299.85161916987,TGFB1
103,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0152108085459522,0,0,19706.0,83157.67014793828,TGFB1
104,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0152108085459522,0,0,19705.0,83086.53988020132,TGFB1
105,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TGFB1
106,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0135665109458835,0,0,19935.0,114209.92613860144,KIT
107,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0135665109458835,0,0,19934.0,113899.85357353876,KIT
108,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0135665109458835,0,0,19903.0,106058.9096435903,KIT
109,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0135665109458835,0,0,19899.0,105233.48101229242,KIT
110,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0135665109458835,0,0,19853.0,97539.10874372096,KIT
111,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0135665109458835,0,0,19852.0,97399.60470052566,KIT
112,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0159498489355705,0,0,19794.0,90569.849337325,KIT
113,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0159498489355705,0,0,19768.0,88101.22480150245,KIT
114,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0180276249433508,0,0,19705.0,83086.53988020132,KIT
115,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,KIT
116,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,KIT
117,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,PLXNC1
118,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0040999250933733,0,0,19959.0,123544.88783416104,BRCC3
119,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,BRCC3
120,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0026999437884725,0,0,19983.0,141285.76583697114,SCP2
121,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0026999437884725,0,0,19973.0,131975.02298599784,SCP2
122,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0041499404726918,0,0,19926.0,111574.38983110404,SCP2
123,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,SCP2
124,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0083999085011095,0,0,19832.0,94787.72752807094,ARID2
125,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,FMO3
126,KEGG_2019_Human,Fatty acid biosynthesis,1/13,0.0006499833083207112,0.0019499499249621,0,0,19987.0,146675.87616784443,FASN
127,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0068499188797651,0,0,19880.0,101706.2448082016,FASN
128,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,FASN
129,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0120748684703449,0,0,19963.0,125618.9446446357,TP53
130,KEGG_2019_Human,Ferroptosis,1/40,0.0019999631680592,0.0120748684703449,0,0,19960.0,124043.94523066044,TP53
131,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0120748684703449,0,0,19959.0,123544.88783416104,TP53
132,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0120748684703449,0,0,19949.0,119129.0228601236,TP53
133,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0120748684703449,0,0,19942.0,116522.31890946148,TP53
134,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0120748684703449,0,0,19937.0,114844.46974572667,TP53
135,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0120748684703449,0,0,19935.0,114209.92613860144,TP53
136,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0120748684703449,0,0,19935.0,114209.92613860144,TP53
137,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0120748684703449,0,0,19934.0,113899.85357353876,TP53
138,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0120748684703449,0,0,19928.0,112131.59838572376,TP53
139,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0120748684703449,0,0,19928.0,112131.59838572376,TP53
140,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0120748684703449,0,0,19925.0,111301.33528642564,TP53
141,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0120748684703449,0,0,19925.0,111301.33528642564,TP53
142,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0120748684703449,0,0,19924.0,111031.8499691117,TP53
143,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0120748684703449,0,0,19914.0,108514.46102290176,TP53
144,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0120748684703449,0,0,19907.0,106918.54242106884,TP53
145,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0120748684703449,0,0,19903.0,106058.9096435903,TP53
146,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0120748684703449,0,0,19898.0,105032.15064717118,TP53
147,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0120748684703449,0,0,19884.0,102400.8105961506,TP53
148,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0120748684703449,0,0,19881.0,101877.73080211312,TP53
149,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0120748684703449,0,0,19881.0,101877.73080211312,TP53
150,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0120748684703449,0,0,19876.0,101034.04709010696,TP53
151,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0120748684703449,0,0,19862.0,98838.19160389496,TP53
152,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0120748684703449,0,0,19861.0,98689.81333375497,TP53
153,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0120748684703449,0,0,19857.0,98106.57763600958,TP53
154,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0120748684703449,0,0,19853.0,97539.10874372096,TP53
155,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0120748684703449,0,0,19851.0,97261.02051561224,TP53
156,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0120748684703449,0,0,19845.0,96448.16254952336,TP53
157,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0120748684703449,0,0,19842.0,96053.2110949472,TP53
158,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0120748684703449,0,0,19840.0,95793.96509856998,TP53
159,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0120748684703449,0,0,19837.0,95410.9786681514,TP53
160,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0120748684703449,0,0,19832.0,94787.72752807094,TP53
161,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0121656667115461,0,0,19814.0,92684.96451050608,TP53
162,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0121656667115461,0,0,19814.0,92684.96451050608,TP53
163,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0121656667115461,0,0,19807.0,91920.47679471428,TP53
164,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0121656667115461,0,0,19799.0,91079.21596609056,TP53
165,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0121656667115461,0,0,19799.0,91079.21596609056,TP53
166,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0121656667115461,0,0,19799.0,91079.21596609056,TP53
167,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0129152591054653,0,0,19781.0,89299.85161916987,TP53
168,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.012937375775889,0,0,19775.0,88738.27077557483,TP53
169,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0163736715972468,0,0,19705.0,83086.53988020132,TP53
170,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0163736715972468,0,0,19701.0,82804.33538735632,TP53
171,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176510210026132,0,0,19670.0,80733.60565076157,TP53
172,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0185044018523381,0,0,19646.0,79255.8617626126,TP53
173,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0251465020680608,0,0,19508.0,72277.44006442746,TP53
174,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TP53
175,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0073998893660899,0,0,19935.0,114209.92613860144,DOCK1
176,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0073998893660899,0,0,19926.0,111574.38983110404,DOCK1
177,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0106998949514067,0,0,19801.0,91286.4288690606,DOCK1
178,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,DOCK1
179,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,MED12
180,KEGG_2019_Human,Non-homologous end-joining,1/13,0.0006499833083207112,0.0006499833083207112,0,0,19987.0,146675.87616784443,XRCC6
181,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0108598853649436,0,0,19910.0,107587.50385474482,BMPR1B
182,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0108598853649436,0,0,19861.0,98689.81333375497,BMPR1B
183,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0108598853649436,0,0,19861.0,98689.81333375497,BMPR1B
184,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0108598853649436,0,0,19840.0,95793.96509856998,BMPR1B
185,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0108598853649436,0,0,19819.0,93248.41634586031,BMPR1B
186,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,BMPR1B
187,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,KDM6A
188,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,KMT2C
189,KEGG_2019_Human,RNA polymerase,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,POLR2B
190,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,POLR2B
191,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0092999029651357,0,0,19935.0,114209.92613860144,PBX1
192,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0092999029651357,0,0,19845.0,96448.16254952336,PBX1
193,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,PBX1
194,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0058999045110413,0,0,19941.0,116175.59385530632,EZH2
195,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,EZH2
196,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,DDX6
197,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,CHIT1
198,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.0028499341869316,0,0,19981.0,139049.2109571672,CYP27B1
199,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0079498959114788,0,0,19894.0,104245.78450366124,CYP27B1
200,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,CYP27B1
201,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL22A1
202,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0058999045110413,0,0,19941.0,116175.59385530632,DOT1L
203,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,DOT1L
204,KEGG_2019_Human,Taurine and hypotaurine metabolism,1/11,0.0005499852259717758,0.0016499556779153,0,0,19989.0,150029.8210287992,GGT1
205,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0031499501598827,0,0,19944.0,117233.87022514464,GGT1
206,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0031499501598827,0,0,19937.0,114844.46974572667,GGT1
207,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0068499188797651,0,0,19928.0,112131.59838572376,PTPN1
208,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0068499188797651,0,0,19892.0,103863.47861844616,PTPN1
209,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PTPN1
210,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0098998669768137,0,0,19926.0,111574.38983110404,PIKFYVE
211,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0098998669768137,0,0,19901.0,105642.09305076736,PIKFYVE
212,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0101332182819961,0,0,19848.0,96850.665715497,PIKFYVE
213,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,PIKFYVE
214,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0023499589392381,0,0,19977.0,135204.63922267244,RFC1
215,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,RFC1
216,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,RFC1
217,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,TBL1XR1
218,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,GTF2I
219,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,GTF2I
220,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,REV3L
221,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0058999045110413,0,0,19941.0,116175.59385530632,KMT2D
222,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,KMT2D
223,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0062499232373748,0,0,19876.0,101034.04709010696,SMC1A
224,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0062499232373748,0,0,19875.0,100869.32368441945,SMC1A
225,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0090499044707863,0,0,19910.0,107587.50385474482,NEO1
226,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0090499044707863,0,0,19855.0,97820.92670675044,NEO1
227,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,NEO1
228,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,UNC5B
229,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,FARSA
230,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.009399902370135,0,0,19902.0,105849.45495286948,ATP2A1
231,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.009399902370135,0,0,19834.0,95034.82345515196,ATP2A1
232,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.009399902370135,0,0,19829.0,94422.42241345016,ATP2A1
233,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,ATP2A1
234,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,EDEM1
235,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,NUP214
236,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR7C1
237,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CNOT1
238,KEGG_2019_Human,Proximal tubule bicarbonate reclamation,1/23,0.0011499748819949,0.0062999150247102,0,0,19977.0,135204.63922267244,ATP1A1
239,KEGG_2019_Human,Aldosterone-regulated sodium reabsorption,1/37,0.0018499650702878,0.0062999150247102,0,0,19963.0,125618.9446446357,ATP1A1
240,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0062999150247102,0,0,19956.0,122117.06559109331,ATP1A1
241,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0062999150247102,0,0,19952.0,120356.5272753826,ATP1A1
242,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0062999150247102,0,0,19949.0,119129.0228601236,ATP1A1
243,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0062999150247102,0,0,19928.0,112131.59838572376,ATP1A1
244,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0062999150247102,0,0,19926.0,111574.38983110404,ATP1A1
245,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0062999150247102,0,0,19925.0,111301.33528642564,ATP1A1
246,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0062999150247102,0,0,19922.0,110503.2180492851,ATP1A1
247,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0062999150247102,0,0,19914.0,108514.46102290176,ATP1A1
248,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1A1
249,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0062999150247102,0,0,19910.0,107587.50385474482,ATP1A1
250,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1A1
251,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,ATP1A1
252,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0069599119814502,0,0,19884.0,102400.8105961506,ATP1A1
253,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0081561555979989,0,0,19855.0,97820.92670675044,ATP1A1
254,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0087881390855717,0,0,19834.0,95034.82345515196,ATP1A1
255,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,ATP1A1
256,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0023499589392381,0,0,19977.0,135204.63922267244,POLD3
257,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0023499589392381,0,0,19967.0,127928.56031580272,POLD3
258,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,POLD3
259,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0023499589392381,0,0,19959.0,123544.88783416104,POLD3
260,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,POLD3
261,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,FAT4
262,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,PLD4
263,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PLD4
264,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF614
265,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0167748446964045,0,0,19935.0,114209.92613860144,FGFR2
266,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0167748446964045,0,0,19903.0,106058.9096435903,FGFR2
267,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0167748446964045,0,0,19861.0,98689.81333375497,FGFR2
268,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0167748446964045,0,0,19851.0,97261.02051561224,FGFR2
269,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0167748446964045,0,0,19794.0,90569.849337325,FGFR2
270,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0167748446964045,0,0,19786.0,89779.39753374986,FGFR2
271,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0167748446964045,0,0,19768.0,88101.22480150245,FGFR2
272,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0167748446964045,0,0,19756.0,87051.4275316661,FGFR2
273,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0180276249433508,0,0,19705.0,83086.53988020132,FGFR2
274,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,FGFR2
275,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FGFR2
276,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0074998996065834,0,0,19931.0,112996.7391397682,EGLN1
277,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0074998996065834,0,0,19900.0,105436.78197328727,EGLN1
278,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,EGLN1
279,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL14A1
280,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0036749366692549,0,0,19960.0,124043.94523066044,DAO
281,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0036749366692549,0,0,19951.0,119939.1172087114,DAO
282,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,DAO
283,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0099998661421113,0,0,19918.0,109484.9180722932,COL4A2
284,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0099998661421113,0,0,19910.0,107587.50385474482,COL4A2
285,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0099998661421113,0,0,19907.0,106918.54242106884,COL4A2
286,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0099998661421113,0,0,19904.0,106270.50039849174,COL4A2
287,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0099998661421113,0,0,19900.0,105436.78197328727,COL4A2
288,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0108332023254213,0,0,19870.0,100064.62842845908,COL4A2
289,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0142141416585942,0,0,19801.0,91286.4288690606,COL4A2
290,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0196665140459632,0,0,19670.0,80733.60565076157,COL4A2
291,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,COL4A2
292,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,COL4A2
293,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0025999452503662,0,0,19974.0,132735.46073187632,PAX6
294,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,PAX6
295,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0127498618039235,0,0,19840.0,95793.96509856998,DLG2
296,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0127498618039235,0,0,19830.0,94543.49009679438,DLG2
297,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,DLG2
298,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,LDB1
299,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,TSPAN7
300,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,SMARCAD1
301,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0124430608970639,0,0,19952.0,120356.5272753826,CREBBP
302,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0124430608970639,0,0,19933.0,113594.38808369274,CREBBP
303,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0124430608970639,0,0,19931.0,112996.7391397682,CREBBP
304,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0124430608970639,0,0,19928.0,112131.59838572376,CREBBP
305,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0124430608970639,0,0,19910.0,107587.50385474482,CREBBP
306,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0124430608970639,0,0,19903.0,106058.9096435903,CREBBP
307,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0124430608970639,0,0,19900.0,105436.78197328727,CREBBP
308,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0124430608970639,0,0,19899.0,105233.48101229242,CREBBP
309,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0124430608970639,0,0,19897.0,104832.7525292024,CREBBP
310,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0124430608970639,0,0,19884.0,102400.8105961506,CREBBP
311,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0124430608970639,0,0,19876.0,101034.04709010696,CREBBP
312,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0124430608970639,0,0,19868.0,99751.22090491928,CREBBP
313,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0124430608970639,0,0,19842.0,96053.2110949472,CREBBP
314,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0124430608970639,0,0,19838.0,95537.86936302872,CREBBP
315,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0124430608970639,0,0,19837.0,95410.9786681514,CREBBP
316,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0124430608970639,0,0,19829.0,94422.42241345016,CREBBP
317,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0124430608970639,0,0,19821.0,93478.0629355712,CREBBP
318,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0124430608970639,0,0,19814.0,92684.96451050608,CREBBP
319,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0124430608970639,0,0,19807.0,91920.47679471428,CREBBP
320,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0124430608970639,0,0,19799.0,91079.21596609056,CREBBP
321,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0124430608970639,0,0,19788.0,89974.27756224656,CREBBP
322,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0124430608970639,0,0,19781.0,89299.85161916987,CREBBP
323,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0162498631163602,0,0,19701.0,82804.33538735632,CREBBP
324,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0171873619364213,0,0,19670.0,80733.60565076157,CREBBP
325,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CREBBP
326,KEGG_2019_Human,Pantothenate and CoA biosynthesis,1/19,0.00094997806231055,0.0030999381313408,0,0,19981.0,139049.2109571672,UPB1
327,KEGG_2019_Human,beta-Alanine metabolism,1/31,0.0015499690656704,0.0030999381313408,0,0,19969.0,129189.85098816035,UPB1
328,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0037999377683973,0,0,19943.0,116875.00742975442,UPB1
329,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UPB1
330,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFS8
331,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFS8
332,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFS8
333,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFS8
334,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFS8
335,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFS8
336,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFS8
337,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ST6GALNAC6
338,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0034999327443191,0,0,19965.0,126740.98858805298,NCAM2
339,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NCAM2
340,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0093748848560622,0,0,19876.0,101034.04709010696,ESPL1
341,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0093748848560622,0,0,19875.0,100869.32368441945,ESPL1
342,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,ESPL1
343,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF729
344,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,VANGL2
345,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF85
346,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZIK1
347,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,SERPINC1
348,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,AKR7A2
349,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EPHB1
350,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0125623732347487,0,0,19896.0,104635.24941415618,STAT2
351,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0125623732347487,0,0,19873.0,100543.72072014232,STAT2
352,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0125623732347487,0,0,19862.0,98838.19160389496,STAT2
353,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0125623732347487,0,0,19845.0,96448.16254952336,STAT2
354,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0125623732347487,0,0,19838.0,95537.86936302872,STAT2
355,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0125623732347487,0,0,19838.0,95537.86936302872,STAT2
356,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0125623732347487,0,0,19837.0,95410.9786681514,STAT2
357,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0125623732347487,0,0,19829.0,94422.42241345016,STAT2
358,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0125623732347487,0,0,19822.0,93593.82745769851,STAT2
359,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0125623732347487,0,0,19814.0,92684.96451050608,STAT2
360,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0125623732347487,0,0,19810.0,92244.74636351672,STAT2
361,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0125623732347487,0,0,19799.0,91079.21596609056,STAT2
362,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0190383086064975,0,0,19670.0,80733.60565076157,STAT2
363,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0263569703353121,0,0,19508.0,72277.44006442746,STAT2
364,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,STAT2
365,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF429
366,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF749
367,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,NRXN1
368,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.0025499566390179,0,0,19958.0,123057.75613441122,HEPH
369,KEGG_2019_Human,Mineral absorption,1/51,0.0025499566390179,0.0025499566390179,0,0,19949.0,119129.0228601236,HEPH
370,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0068499188797651,0,0,19872.0,100382.8010329652,PIK3R4
371,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,PIK3R4
372,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF234
373,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PTPRR
374,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0089499050800561,0,0,19848.0,96850.665715497,MRC2
375,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0089499050800561,0,0,19821.0,93478.0629355712,MRC2
376,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,DTX3
377,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBOX5
378,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0080999104202618,0,0,19930.0,112704.30065625212,CYLD
379,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0080999104202618,0,0,19896.0,104635.24941415618,CYLD
380,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0080999104202618,0,0,19873.0,100543.72072014232,CYLD
381,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,CYLD
382,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0076499133771537,0,0,19880.0,101706.2448082016,EEF2K
383,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,EEF2K
384,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0096998686609413,0,0,19935.0,114209.92613860144,CD44
385,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.0096998686609413,0,0,19918.0,109484.9180722932,CD44
386,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0096998686609413,0,0,19903.0,106058.9096435903,CD44
387,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,CD44
388,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0120598783053587,0,0,19799.0,91079.21596609056,CD44
389,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,CD44
390,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0049199291157828,0,0,19958.0,123057.75613441122,CYP1B1
391,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0049199291157828,0,0,19951.0,119939.1172087114,CYP1B1
392,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0049199291157828,0,0,19940.0,115834.63209072244,CYP1B1
393,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0049199291157828,0,0,19926.0,111574.38983110404,CYP1B1
394,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0049199291157828,0,0,19918.0,109484.9180722932,CYP1B1
395,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,CYP1B1
396,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,PYCR1
397,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0079623895876056,0,0,19928.0,112131.59838572376,CACNA2D4
398,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0079623895876056,0,0,19922.0,110503.2180492851,CACNA2D4
399,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0079623895876056,0,0,19915.0,108752.83801948265,CACNA2D4
400,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0079623895876056,0,0,19909.0,107362.10783923086,CACNA2D4
401,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0089248989400127,0,0,19855.0,97820.92670675044,CACNA2D4
402,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0089248989400127,0,0,19847.0,96715.6407630817,CACNA2D4
403,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA2D4
404,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0057999266512085,0,0,19884.0,102400.8105961506,MED13L
405,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFS4
406,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFS4
407,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFS4
408,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFS4
409,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFS4
410,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFS4
411,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFS4
412,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0038499432547502,0,0,19923.0,110765.8407373636,KIR3DL3
413,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0045499369072032,0,0,19915.0,108752.83801948265,TTN
414,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,TTN
415,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF599
416,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0148498004652205,0,0,19935.0,114209.92613860144,PDGFRB
417,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0148498004652205,0,0,19928.0,112131.59838572376,PDGFRB
418,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0148498004652205,0,0,19925.0,111301.33528642564,PDGFRB
419,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0148498004652205,0,0,19912.0,108045.79305232369,PDGFRB
420,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0148498004652205,0,0,19903.0,106058.9096435903,PDGFRB
421,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0148498004652205,0,0,19901.0,105642.09305076736,PDGFRB
422,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0160498424271101,0,0,19852.0,97399.60470052566,PDGFRB
423,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0160498424271101,0,0,19838.0,95537.86936302872,PDGFRB
424,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0160498424271101,0,0,19812.0,92463.712994847,PDGFRB
425,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0160498424271101,0,0,19801.0,91286.4288690606,PDGFRB
426,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0160498424271101,0,0,19794.0,90569.849337325,PDGFRB
427,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0160498424271101,0,0,19786.0,89779.39753374986,PDGFRB
428,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0160613863407144,0,0,19768.0,88101.22480150245,PDGFRB
429,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0179398488804617,0,0,19705.0,83086.53988020132,PDGFRB
430,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0179398488804617,0,0,19701.0,82804.33538735632,PDGFRB
431,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.018562350891335,0,0,19670.0,80733.60565076157,PDGFRB
432,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0187410310320355,0,0,19646.0,79255.8617626126,PDGFRB
433,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PDGFRB
434,KEGG_2019_Human,Mitophagy,1/65,0.003249949134407,0.0075999137114971,0,0,19935.0,114209.92613860144,ULK1
435,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0075999137114971,0,0,19898.0,105032.15064717118,ULK1
436,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0075999137114971,0,0,19880.0,101706.2448082016,ULK1
437,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0075999137114971,0,0,19872.0,100382.8010329652,ULK1
438,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,ULK1
439,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBR5
440,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,A2M
441,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0092999029651357,0,0,19910.0,107587.50385474482,SMAD1
442,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0092999029651357,0,0,19861.0,98689.81333375497,SMAD1
443,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0092999029651357,0,0,19840.0,95793.96509856998,SMAD1
444,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,SMAD1
445,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0059249134751006,0,0,19932.0,113293.39338050144,FGG
446,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0059249134751006,0,0,19921.0,110243.89578070649,FGG
447,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,FGG
448,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0078999117225733,0,0,19842.0,96053.2110949472,LGR5
449,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0108798323891805,0,0,19960.0,124043.94523066044,GRIN2A
450,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0108798323891805,0,0,19951.0,119939.1172087114,GRIN2A
451,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0108798323891805,0,0,19949.0,119129.0228601236,GRIN2A
452,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0108798323891805,0,0,19933.0,113594.38808369274,GRIN2A
453,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0108798323891805,0,0,19932.0,113293.39338050144,GRIN2A
454,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0118220805500286,0,0,19903.0,106058.9096435903,GRIN2A
455,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0118220805500286,0,0,19886.0,102756.96431429044,GRIN2A
456,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0118220805500286,0,0,19869.0,99907.33811343512,GRIN2A
457,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0118220805500286,0,0,19867.0,99596.2591544721,GRIN2A
458,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0121141662887149,0,0,19829.0,94422.42241345016,GRIN2A
459,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0121141662887149,0,0,19820.0,93362.92821536642,GRIN2A
460,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0121141662887149,0,0,19812.0,92463.712994847,GRIN2A
461,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0121141662887149,0,0,19794.0,90569.849337325,GRIN2A
462,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0121141662887149,0,0,19788.0,89974.27756224656,GRIN2A
463,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123732161439577,0,0,19768.0,88101.22480150245,GRIN2A
464,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIN2A
465,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,WDR36
466,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0141331940035007,0,0,19887.0,102937.34947211576,HTR4
467,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0141331940035007,0,0,19812.0,92463.712994847,HTR4
468,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,HTR4
469,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,HTR4
470,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0061874168605085,0,0,19939.0,115499.24335773686,DGKI
471,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0061874168605085,0,0,19903.0,106058.9096435903,DGKI
472,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKI
473,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKI
474,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,DGKI
475,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5D13
476,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,KMT2E
477,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF563
478,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0147498749536506,0,0,19799.0,91079.21596609056,RASA2
479,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0147498749536506,0,0,19768.0,88101.22480150245,RASA2
480,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RASA2
481,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,SLC7A7
482,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0114098741370135,0,0,19876.0,101034.04709010696,YWHAB
483,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0114098741370135,0,0,19875.0,100869.32368441945,YWHAB
484,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0114098741370135,0,0,19845.0,96448.16254952336,YWHAB
485,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0114098741370135,0,0,19840.0,95793.96509856998,YWHAB
486,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0114098741370135,0,0,19837.0,95410.9786681514,YWHAB
487,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0117248816857654,0,0,19799.0,91079.21596609056,YWHAB
488,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,YWHAB
489,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF285
490,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0036999446830449,0,0,19935.0,114209.92613860144,ELMO2
491,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ELMO2
492,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0122180487288865,0,0,19963.0,125618.9446446357,MYC
493,KEGG_2019_Human,Bladder cancer,1/41,0.0020499625466866,0.0122180487288865,0,0,19959.0,123544.88783416104,MYC
494,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0122180487288865,0,0,19942.0,116522.31890946148,MYC
495,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0122180487288865,0,0,19935.0,114209.92613860144,MYC
496,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0122180487288865,0,0,19934.0,113899.85357353876,MYC
497,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0122180487288865,0,0,19924.0,111031.8499691117,MYC
498,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0122180487288865,0,0,19915.0,108752.83801948265,MYC
499,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0122180487288865,0,0,19914.0,108514.46102290176,MYC
500,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.0122180487288865,0,0,19910.0,107587.50385474482,MYC
501,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0122180487288865,0,0,19907.0,106918.54242106884,MYC
502,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0122180487288865,0,0,19884.0,102400.8105961506,MYC
503,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0122180487288865,0,0,19876.0,101034.04709010696,MYC
504,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0122180487288865,0,0,19861.0,98689.81333375497,MYC
505,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0122180487288865,0,0,19853.0,97539.10874372096,MYC
506,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0122180487288865,0,0,19851.0,97261.02051561224,MYC
507,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0122180487288865,0,0,19845.0,96448.16254952336,MYC
508,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0122180487288865,0,0,19842.0,96053.2110949472,MYC
509,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0122180487288865,0,0,19840.0,95793.96509856998,MYC
510,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0122180487288865,0,0,19840.0,95793.96509856998,MYC
511,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0122180487288865,0,0,19838.0,95537.86936302872,MYC
512,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0122180487288865,0,0,19837.0,95410.9786681514,MYC
513,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0122180487288865,0,0,19832.0,94787.72752807094,MYC
514,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0123691059542141,0,0,19814.0,92684.96451050608,MYC
515,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0123691059542141,0,0,19814.0,92684.96451050608,MYC
516,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0123691059542141,0,0,19799.0,91079.21596609056,MYC
517,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0123691059542141,0,0,19799.0,91079.21596609056,MYC
518,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0128570194046101,0,0,19781.0,89299.85161916987,MYC
519,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0128570194046101,0,0,19775.0,88738.27077557483,MYC
520,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0159465323381882,0,0,19705.0,83086.53988020132,MYC
521,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0159465323381882,0,0,19701.0,82804.33538735632,MYC
522,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0182708259523787,0,0,19646.0,79255.8617626126,MYC
523,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,MYC
524,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0088999053857096,0,0,19847.0,96715.6407630817,TRPM2
525,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,TRPM2
526,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0147498749536506,0,0,19801.0,91286.4288690606,RASGRF1
527,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0147498749536506,0,0,19768.0,88101.22480150245,RASGRF1
528,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,RASGRF1
529,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0122346591503639,0,0,19945.0,117599.1294878737,CASP8
530,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0122346591503639,0,0,19941.0,116175.59385530632,CASP8
531,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0122346591503639,0,0,19930.0,112704.30065625212,CASP8
532,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0122346591503639,0,0,19928.0,112131.59838572376,CASP8
533,KEGG_2019_Human,IL-17 signaling pathway,1/93,0.0046499360391879,0.0122346591503639,0,0,19907.0,106918.54242106884,CASP8
534,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0122346591503639,0,0,19897.0,104832.7525292024,CASP8
535,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0122346591503639,0,0,19896.0,104635.24941415618,CASP8
536,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0122346591503639,0,0,19896.0,104635.24941415618,CASP8
537,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0122346591503639,0,0,19890.0,103488.06969787036,CASP8
538,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0122346591503639,0,0,19887.0,102937.34947211576,CASP8
539,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0122346591503639,0,0,19862.0,98838.19160389496,CASP8
540,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0122346591503639,0,0,19857.0,98106.57763600958,CASP8
541,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0122346591503639,0,0,19851.0,97261.02051561224,CASP8
542,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0122346591503639,0,0,19845.0,96448.16254952336,CASP8
543,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0122346591503639,0,0,19838.0,95537.86936302872,CASP8
544,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0122346591503639,0,0,19837.0,95410.9786681514,CASP8
545,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0122346591503639,0,0,19829.0,94422.42241345016,CASP8
546,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0122346591503639,0,0,19822.0,93593.82745769851,CASP8
547,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0122346591503639,0,0,19821.0,93478.0629355712,CASP8
548,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0122346591503639,0,0,19814.0,92684.96451050608,CASP8
549,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0122346591503639,0,0,19807.0,91920.47679471428,CASP8
550,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0122346591503639,0,0,19799.0,91079.21596609056,CASP8
551,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0122346591503639,0,0,19799.0,91079.21596609056,CASP8
552,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0123665447530631,0,0,19788.0,89974.27756224656,CASP8
553,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0125998790165179,0,0,19775.0,88738.27077557483,CASP8
554,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.017769088032731,0,0,19670.0,80733.60565076157,CASP8
555,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0255109441270182,0,0,19508.0,72277.44006442746,CASP8
556,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CASP8
557,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0101998428648568,0,0,19960.0,124043.94523066044,GRIN1
558,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0101998428648568,0,0,19951.0,119939.1172087114,GRIN1
559,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0101998428648568,0,0,19949.0,119129.0228601236,GRIN1
560,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0101998428648568,0,0,19933.0,113594.38808369274,GRIN1
561,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0101998428648568,0,0,19932.0,113293.39338050144,GRIN1
562,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0121248358261767,0,0,19903.0,106058.9096435903,GRIN1
563,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0122141302025121,0,0,19886.0,102756.96431429044,GRIN1
564,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0122306486568756,0,0,19829.0,94422.42241345016,GRIN1
565,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0122306486568756,0,0,19820.0,93362.92821536642,GRIN1
566,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0122306486568756,0,0,19812.0,92463.712994847,GRIN1
567,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0122306486568756,0,0,19807.0,91920.47679471428,GRIN1
568,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0122306486568756,0,0,19794.0,90569.849337325,GRIN1
569,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0122306486568756,0,0,19788.0,89974.27756224656,GRIN1
570,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.012428453716029,0,0,19768.0,88101.22480150245,GRIN1
571,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIN1
572,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.006949918172816,0,0,19861.0,98689.81333375497,TBX3
573,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0047999275336174,0,0,19950.0,119530.05920663515,NCEH1
574,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0047999275336174,0,0,19935.0,114209.92613860144,NCEH1
575,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0047999275336174,0,0,19928.0,112131.59838572376,NCEH1
576,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,NCEH1
577,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EFNB1
578,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0047999347538706,0,0,19904.0,106270.50039849174,SERPINB13
579,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0061999236097501,0,0,19876.0,101034.04709010696,CDC14A
580,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF716
581,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0083998866996136,0,0,19928.0,112131.59838572376,RYR2
582,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0083998866996136,0,0,19922.0,110503.2180492851,RYR2
583,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.0083998866996136,0,0,19915.0,108752.83801948265,RYR2
584,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0083998866996136,0,0,19914.0,108514.46102290176,RYR2
585,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0083998866996136,0,0,19909.0,107362.10783923086,RYR2
586,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0083998866996136,0,0,19903.0,106058.9096435903,RYR2
587,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0083998866996136,0,0,19902.0,105849.45495286948,RYR2
588,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0091798960525845,0,0,19863.0,98987.62735269018,RYR2
589,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0091798960525845,0,0,19855.0,97820.92670675044,RYR2
590,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0091798960525845,0,0,19847.0,96715.6407630817,RYR2
591,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0102544389492382,0,0,19812.0,92463.712994847,RYR2
592,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,RYR2
593,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,EXOSC9
594,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0027999423465995,0,0,19972.0,131242.0761597353,PDE6A
595,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PDE6A
596,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF8
597,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,DPP4
598,KEGG_2019_Human,Primary bile acid biosynthesis,1/17,0.0008499797390404818,0.0020249578413544,0,0,19983.0,141285.76583697114,HSD17B4
599,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0020249578413544,0,0,19973.0,131975.02298599784,HSD17B4
600,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,HSD17B4
601,KEGG_2019_Human,Primary immunodeficiency,1/37,0.0018499650702878,0.0063124158183504,0,0,19963.0,125618.9446446357,CD8A
602,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0063124158183504,0,0,19923.0,110765.8407373636,CD8A
603,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0063124158183504,0,0,19903.0,106058.9096435903,CD8A
604,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0063124158183504,0,0,19899.0,105233.48101229242,CD8A
605,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CD8A
606,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF254
607,KEGG_2019_Human,Amyotrophic lateral sclerosis (ALS),1/51,0.0025499566390179,0.0109665527651575,0,0,19949.0,119129.0228601236,PPP3R1
608,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0109665527651575,0,0,19941.0,116175.59385530632,PPP3R1
609,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0109665527651575,0,0,19933.0,113594.38808369274,PPP3R1
610,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0109665527651575,0,0,19932.0,113293.39338050144,PPP3R1
611,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0109665527651575,0,0,19931.0,112996.7391397682,PPP3R1
612,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0109665527651575,0,0,19929.0,112415.9585341616,PPP3R1
613,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0109665527651575,0,0,19908.0,107139.13814408927,PPP3R1
614,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0109665527651575,0,0,19899.0,105233.48101229242,PPP3R1
615,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0109665527651575,0,0,19897.0,104832.7525292024,PPP3R1
616,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0109665527651575,0,0,19896.0,104635.24941415618,PPP3R1
617,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0109665527651575,0,0,19893.0,104053.753408911,PPP3R1
618,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0109665527651575,0,0,19886.0,102756.96431429044,PPP3R1
619,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0109665527651575,0,0,19875.0,100869.32368441945,PPP3R1
620,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0109665527651575,0,0,19873.0,100543.72072014232,PPP3R1
621,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0109665527651575,0,0,19869.0,99907.33811343512,PPP3R1
622,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0109665527651575,0,0,19847.0,96715.6407630817,PPP3R1
623,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109665527651575,0,0,19842.0,96053.2110949472,PPP3R1
624,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0109665527651575,0,0,19840.0,95793.96509856998,PPP3R1
625,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0109665527651575,0,0,19834.0,95034.82345515196,PPP3R1
626,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0109665527651575,0,0,19829.0,94422.42241345016,PPP3R1
627,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0109665527651575,0,0,19821.0,93478.0629355712,PPP3R1
628,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0109665527651575,0,0,19819.0,93248.41634586031,PPP3R1
629,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0109665527651575,0,0,19814.0,92684.96451050608,PPP3R1
630,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109665527651575,0,0,19812.0,92463.712994847,PPP3R1
631,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.011666554644924,0,0,19788.0,89974.27756224656,PPP3R1
632,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.011666554644924,0,0,19781.0,89299.85161916987,PPP3R1
633,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.011666554644924,0,0,19775.0,88738.27077557483,PPP3R1
634,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PPP3R1
635,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0082499094553477,0,0,19848.0,96850.665715497,SEH1L
636,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,SEH1L
637,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0091332251730202,0,0,19954.0,121217.8313311442,PRKCE
638,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0091332251730202,0,0,19909.0,107362.10783923086,PRKCE
639,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0091332251730202,0,0,19902.0,105849.45495286948,PRKCE
640,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0091332251730202,0,0,19900.0,105436.78197328727,PRKCE
641,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0091332251730202,0,0,19900.0,105436.78197328727,PRKCE
642,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0091332251730202,0,0,19892.0,103863.47861844616,PRKCE
643,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0091332251730202,0,0,19881.0,101877.73080211312,PRKCE
644,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0091332251730202,0,0,19868.0,99751.22090491928,PRKCE
645,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0091332251730202,0,0,19863.0,98987.62735269018,PRKCE
646,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0092726267664898,0,0,19834.0,95034.82345515196,PRKCE
647,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0092726267664898,0,0,19830.0,94543.49009679438,PRKCE
648,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,PRKCE
649,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,PLXNB3
650,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0044999202394188,0,0,19955.0,121662.49782449217,ABCB9
651,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0061499239842961,0,0,19877.0,101200.07933676826,ABCB9
652,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF107
653,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0021999607179423,0,0,19969.0,129189.85098816035,MGAM2
654,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0021999607179423,0,0,19964.0,126172.23364250171,MGAM2
655,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,MGAM2
656,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0097998932512944,0,0,19894.0,104245.78450366124,LRP6
657,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0097998932512944,0,0,19853.0,97539.10874372096,LRP6
658,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0097998932512944,0,0,19851.0,97261.02051561224,LRP6
659,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0097998932512944,0,0,19848.0,96850.665715497,LRP6
660,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0097998932512944,0,0,19842.0,96053.2110949472,LRP6
661,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0097998932512944,0,0,19832.0,94787.72752807094,LRP6
662,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,LRP6
663,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0024999572069037,0,0,19976.0,134347.69487847842,APOA4
664,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0024999572069037,0,0,19959.0,123544.88783416104,APOA4
665,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,APOA4
666,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,NAT10
667,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,CNTNAP1
668,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR5A2
669,KEGG_2019_Human,Prion diseases,1/35,0.0017499663721595,0.0059249134751006,0,0,19965.0,126740.98858805298,C1QC
670,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0059249134751006,0,0,19932.0,113293.39338050144,C1QC
671,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0059249134751006,0,0,19924.0,111031.8499691117,C1QC
672,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0059249134751006,0,0,19921.0,110243.89578070649,C1QC
673,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.006179918196314,0,0,19897.0,104832.7525292024,C1QC
674,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0066499203093911,0,0,19867.0,99596.2591544721,C1QC
675,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF282
676,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF761
677,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,TAAR9
678,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF587
679,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,ACTR3B
680,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SLC22A5
681,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,ABCA8
682,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0036999446830449,0,0,19933.0,113594.38808369274,CYP2S1
683,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,CYP2S1
684,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,PFAS
685,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,SIGLEC1
686,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0097998311180133,0,0,19951.0,119939.1172087114,GRM2
687,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.009866553415188,0,0,19886.0,102756.96431429044,GRM2
688,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.009866553415188,0,0,19852.0,97399.60470052566,GRM2
689,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRM2
690,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0048999339081079,0,0,19928.0,112131.59838572376,SLC4A2
691,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0048999339081079,0,0,19925.0,111301.33528642564,SLC4A2
692,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0048999339081079,0,0,19910.0,107587.50385474482,SLC4A2
693,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0048999339081079,0,0,19902.0,105849.45495286948,SLC4A2
694,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0096665547828135,0,0,19909.0,107362.10783923086,PPP2R5B
695,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0096665547828135,0,0,19881.0,101877.73080211312,PPP2R5B
696,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0096665547828135,0,0,19880.0,101706.2448082016,PPP2R5B
697,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0096665547828135,0,0,19875.0,100869.32368441945,PPP2R5B
698,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0096665547828135,0,0,19869.0,99907.33811343512,PPP2R5B
699,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0096665547828135,0,0,19855.0,97820.92670675044,PPP2R5B
700,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,PPP2R5B
701,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PPP2R5B
702,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0097998678162159,0,0,19902.0,105849.45495286948,PRKD1
703,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.010299897173561,0,0,19794.0,90569.849337325,PRKD1
704,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH17
705,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,HEATR1
706,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG2B
707,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0082999091363732,0,0,19894.0,104245.78450366124,MEF2A
708,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0082999091363732,0,0,19863.0,98987.62735269018,MEF2A
709,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0082999091363732,0,0,19861.0,98689.81333375497,MEF2A
710,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,MEF2A
711,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,KDM3B
712,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0093498670474992,0,0,19945.0,117599.1294878737,ABL1
713,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0093498670474992,0,0,19941.0,116175.59385530632,ABL1
714,KEGG_2019_Human,Shigellosis,1/65,0.003249949134407,0.0093498670474992,0,0,19935.0,114209.92613860144,ABL1
715,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0093498670474992,0,0,19924.0,111031.8499691117,ABL1
716,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0093498670474992,0,0,19915.0,108752.83801948265,ABL1
717,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0097427371010359,0,0,19881.0,101877.73080211312,ABL1
718,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0097427371010359,0,0,19876.0,101034.04709010696,ABL1
719,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0124436186473312,0,0,19819.0,93248.41634586031,ABL1
720,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0141776434982849,0,0,19768.0,88101.22480150245,ABL1
721,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0164448614737565,0,0,19701.0,82804.33538735632,ABL1
722,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ABL1
723,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYH13
724,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0020499625466866,0,0,19959.0,123544.88783416104,XRCC3
725,KEGG_2019_Human,Ribosome,1/153,0.0076499133771537,0.0076499133771537,0,0,19847.0,96715.6407630817,RPL4
726,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.0041499404726918,0,0,19955.0,121662.49782449217,ABCD1
727,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,ABCD1
728,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.0064998982688141,0,0,19940.0,115834.63209072244,CYP21A2
729,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0064998982688141,0,0,19935.0,114209.92613860144,CYP21A2
730,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0065332452108106,0,0,19902.0,105849.45495286948,CYP21A2
731,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0077499127120574,0,0,19845.0,96448.16254952336,CYP21A2
732,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0084999078692823,0,0,19932.0,113293.39338050144,F11R
733,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0084999078692823,0,0,19888.0,103119.30984392198,F11R
734,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0084999078692823,0,0,19855.0,97820.92670675044,F11R
735,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,F11R
736,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,CARS2
737,KEGG_2019_Human,ABC transporters,1/45,0.0022499601197094,0.007499888408225,0,0,19955.0,121662.49782449217,CFTR
738,KEGG_2019_Human,Vibrio cholerae infection,1/50,0.0024999572069037,0.007499888408225,0,0,19950.0,119530.05920663515,CFTR
739,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.007499888408225,0,0,19928.0,112131.59838572376,CFTR
740,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.007499888408225,0,0,19925.0,111301.33528642564,CFTR
741,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0078398942529727,0,0,19902.0,105849.45495286948,CFTR
742,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0079999001574478,0,0,19880.0,101706.2448082016,CFTR
743,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0097141804220369,0,0,19830.0,94543.49009679438,CFTR
744,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,CFTR
745,KEGG_2019_Human,African trypanosomiasis,1/37,0.0018499650702878,0.0095533816179956,0,0,19963.0,125618.9446446357,PLCB2
746,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0095533816179956,0,0,19956.0,122117.06559109331,PLCB2
747,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0095533816179956,0,0,19952.0,120356.5272753826,PLCB2
748,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0095533816179956,0,0,19940.0,115834.63209072244,PLCB2
749,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0095533816179956,0,0,19935.0,114209.92613860144,PLCB2
750,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0095533816179956,0,0,19933.0,113594.38808369274,PLCB2
751,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0095533816179956,0,0,19931.0,112996.7391397682,PLCB2
752,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0095533816179956,0,0,19926.0,111574.38983110404,PLCB2
753,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0095533816179956,0,0,19926.0,111574.38983110404,PLCB2
754,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0095533816179956,0,0,19925.0,111301.33528642564,PLCB2
755,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0095533816179956,0,0,19917.0,109237.99888847338,PLCB2
756,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0095533816179956,0,0,19914.0,108514.46102290176,PLCB2
757,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0095533816179956,0,0,19912.0,108045.79305232369,PLCB2
758,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0095533816179956,0,0,19910.0,107587.50385474482,PLCB2
759,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0095533816179956,0,0,19907.0,106918.54242106884,PLCB2
760,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0095533816179956,0,0,19904.0,106270.50039849174,PLCB2
761,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0095533816179956,0,0,19903.0,106058.9096435903,PLCB2
762,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0095533816179956,0,0,19902.0,105849.45495286948,PLCB2
763,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0095533816179956,0,0,19902.0,105849.45495286948,PLCB2
764,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0095533816179956,0,0,19901.0,105642.09305076736,PLCB2
765,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0095533816179956,0,0,19900.0,105436.78197328727,PLCB2
766,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0095533816179956,0,0,19900.0,105436.78197328727,PLCB2
767,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0095533816179956,0,0,19899.0,105233.48101229242,PLCB2
768,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0095533816179956,0,0,19897.0,104832.7525292024,PLCB2
769,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0095533816179956,0,0,19897.0,104832.7525292024,PLCB2
770,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0095533816179956,0,0,19894.0,104245.78450366124,PLCB2
771,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0095533816179956,0,0,19888.0,103119.30984392198,PLCB2
772,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0095533816179956,0,0,19887.0,102937.34947211576,PLCB2
773,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0095533816179956,0,0,19886.0,102756.96431429044,PLCB2
774,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0095533816179956,0,0,19884.0,102400.8105961506,PLCB2
775,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0095533816179956,0,0,19881.0,101877.73080211312,PLCB2
776,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0095533816179956,0,0,19876.0,101034.04709010696,PLCB2
777,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0095533816179956,0,0,19870.0,100064.62842845908,PLCB2
778,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0095533816179956,0,0,19869.0,99907.33811343512,PLCB2
779,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0095533816179956,0,0,19868.0,99751.22090491928,PLCB2
780,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0095533816179956,0,0,19863.0,98987.62735269018,PLCB2
781,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0095533816179956,0,0,19863.0,98987.62735269018,PLCB2
782,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0095533816179956,0,0,19855.0,97820.92670675044,PLCB2
783,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0095533816179956,0,0,19852.0,97399.60470052566,PLCB2
784,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0095533816179956,0,0,19852.0,97399.60470052566,PLCB2
785,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0095533816179956,0,0,19847.0,96715.6407630817,PLCB2
786,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0095533816179956,0,0,19845.0,96448.16254952336,PLCB2
787,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0095533816179956,0,0,19842.0,96053.2110949472,PLCB2
788,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0098089835248047,0,0,19834.0,95034.82345515196,PLCB2
789,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0098798931755488,0,0,19829.0,94422.42241345016,PLCB2
790,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0100607626099326,0,0,19822.0,93593.82745769851,PLCB2
791,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0102407111562755,0,0,19812.0,92463.712994847,PLCB2
792,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0102407111562755,0,0,19810.0,92244.74636351672,PLCB2
793,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0102407111562755,0,0,19807.0,91920.47679471428,PLCB2
794,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0107118930605034,0,0,19794.0,90569.849337325,PLCB2
795,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0114704780962698,0,0,19775.0,88738.27077557483,PLCB2
796,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,PLCB2
797,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SLC22A3
798,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,LSS
799,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,RASAL2
800,KEGG_2019_Human,Steroid biosynthesis,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,SQLE
801,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0109165350527672,0,0,19932.0,113293.39338050144,PTPN11
802,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0109165350527672,0,0,19931.0,112996.7391397682,PTPN11
803,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0109165350527672,0,0,19931.0,112996.7391397682,PTPN11
804,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0109165350527672,0,0,19924.0,111031.8499691117,PTPN11
805,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0109165350527672,0,0,19896.0,104635.24941415618,PTPN11
806,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0109165350527672,0,0,19892.0,103863.47861844616,PTPN11
807,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0109165350527672,0,0,19888.0,103119.30984392198,PTPN11
808,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0109165350527672,0,0,19881.0,101877.73080211312,PTPN11
809,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0109165350527672,0,0,19869.0,99907.33811343512,PTPN11
810,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0110453323912661,0,0,19852.0,97399.60470052566,PTPN11
811,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0110453323912661,0,0,19838.0,95537.86936302872,PTPN11
812,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0113123805884829,0,0,19819.0,93248.41634586031,PTPN11
813,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0115960368320757,0,0,19799.0,91079.21596609056,PTPN11
814,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.012428453716029,0,0,19768.0,88101.22480150245,PTPN11
815,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,PTPN11
816,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.0112582177134695,0,0,19922.0,110503.2180492851,UQCRB
817,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,UQCRB
818,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,UQCRB
819,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,UQCRB
820,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,UQCRB
821,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,UQCRB
822,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,UQCRB
823,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0017999657178272,0,0,19964.0,126172.23364250171,GBA3
824,KEGG_2019_Human,Synthesis and degradation of ketone bodies,1/10,0.0004999862257578379,0.0026399541924786,0,0,19990.0,151942.5908680334,ACAT2
825,KEGG_2019_Human,Terpenoid backbone biosynthesis,1/22,0.0010999756574123,0.0026399541924786,0,0,19978.0,136099.47030191717,ACAT2
826,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0026399541924786,0,0,19972.0,131242.0761597353,ACAT2
827,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0026399541924786,0,0,19970.0,129851.13732048514,ACAT2
828,KEGG_2019_Human,Propanoate metabolism,1/32,0.0015999683804467,0.0026399541924786,0,0,19968.0,128549.41955786056,ACAT2
829,KEGG_2019_Human,Pyruvate metabolism,1/39,0.0019499637955508,0.0026399541924786,0,0,19961.0,124555.53162481484,ACAT2
830,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0026399541924786,0,0,19959.0,123544.88783416104,ACAT2
831,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0026399541924786,0,0,19958.0,123057.75613441122,ACAT2
832,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0026399541924786,0,0,19956.0,122117.06559109331,ACAT2
833,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0026399541924786,0,0,19952.0,120356.5272753826,ACAT2
834,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,ACAT2
835,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF155
836,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH11
837,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0063499224962247,0,0,19929.0,112415.9585341616,LILRB3
838,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0063499224962247,0,0,19873.0,100543.72072014232,LILRB3
839,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF546
840,KEGG_2019_Human,Non-homologous end-joining,1/13,0.0006499833083207112,0.0019499499249621,0,0,19987.0,146675.87616784443,MRE11
841,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0030749438200299,0,0,19959.0,123544.88783416104,MRE11
842,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,MRE11
843,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.007274901495706,0,0,19939.0,115499.24335773686,AGPAT5
844,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.007274901495706,0,0,19903.0,106058.9096435903,AGPAT5
845,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,AGPAT5
846,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0052874076132858,0,0,19975.0,133525.54486996148,PLA2G5
847,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0052874076132858,0,0,19971.0,130534.69172799008,PLA2G5
848,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0052874076132858,0,0,19959.0,123544.88783416104,PLA2G5
849,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0052874076132858,0,0,19953.0,120782.64067395544,PLA2G5
850,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.005669910287789,0,0,19937.0,114844.46974572667,PLA2G5
851,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0062999150247102,0,0,19903.0,106058.9096435903,PLA2G5
852,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0062999150247102,0,0,19902.0,105849.45495286948,PLA2G5
853,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0074249107536368,0,0,19868.0,99751.22090491928,PLA2G5
854,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLA2G5
855,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR2Z1
856,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,UBE4A
857,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0035999314356544,0,0,19964.0,126172.23364250171,TYR
858,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,TYR
859,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.009899892959305,0,0,19935.0,114209.92613860144,CACNA1F
860,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.009899892959305,0,0,19931.0,112996.7391397682,CACNA1F
861,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.009899892959305,0,0,19928.0,112131.59838572376,CACNA1F
862,KEGG_2019_Human,Cardiac muscle contraction,1/78,0.0038999427840466,0.009899892959305,0,0,19922.0,110503.2180492851,CACNA1F
863,KEGG_2019_Human,Hypertrophic cardiomyopathy (HCM),1/85,0.004249939567045,0.009899892959305,0,0,19915.0,108752.83801948265,CACNA1F
864,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.009899892959305,0,0,19914.0,108514.46102290176,CACNA1F
865,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.009899892959305,0,0,19911.0,107815.380281759,CACNA1F
866,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.009899892959305,0,0,19909.0,107362.10783923086,CACNA1F
867,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.009899892959305,0,0,19907.0,106918.54242106884,CACNA1F
868,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.009899892959305,0,0,19902.0,105849.45495286948,CACNA1F
869,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.009899892959305,0,0,19888.0,103119.30984392198,CACNA1F
870,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.009899892959305,0,0,19887.0,102937.34947211576,CACNA1F
871,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.009899892959305,0,0,19868.0,99751.22090491928,CACNA1F
872,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.009899892959305,0,0,19855.0,97820.92670675044,CACNA1F
873,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.009899892959305,0,0,19852.0,97399.60470052566,CACNA1F
874,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.009899892959305,0,0,19847.0,96715.6407630817,CACNA1F
875,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.009899892959305,0,0,19845.0,96448.16254952336,CACNA1F
876,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.009899892959305,0,0,19834.0,95034.82345515196,CACNA1F
877,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.009899892959305,0,0,19829.0,94422.42241345016,CACNA1F
878,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0103398926071485,0,0,19812.0,92463.712994847,CACNA1F
879,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.011104652431322,0,0,19788.0,89974.27756224656,CACNA1F
880,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA1F
881,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0039499423167337,0,0,19932.0,113293.39338050144,CFH
882,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CFH
883,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,CERS3
884,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0059499254985137,0,0,19881.0,101877.73080211312,CERS3
885,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0044499377838098,0,0,19911.0,107815.380281759,SLC12A5
886,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,BRK1
887,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,IQGAP2
888,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0202497760506546,0,0,19903.0,106058.9096435903,CSF3R
889,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0202497760506546,0,0,19838.0,95537.86936302872,CSF3R
890,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0221248283017086,0,0,19706.0,83157.67014793828,CSF3R
891,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0221248283017086,0,0,19646.0,79255.8617626126,CSF3R
892,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CSF3R
893,KEGG_2019_Human,Ascorbate and aldarate metabolism,1/27,0.0013499718942362,0.004685646776936,0,0,19973.0,131975.02298599784,UGT1A6
894,KEGG_2019_Human,Pentose and glucuronate interconversions,1/34,0.0016999670339032,0.004685646776936,0,0,19966.0,127326.1054203148,UGT1A6
895,KEGG_2019_Human,Porphyrin and chlorophyll metabolism,1/42,0.0020999619311272,0.004685646776936,0,0,19958.0,123057.75613441122,UGT1A6
896,KEGG_2019_Human,Steroid hormone biosynthesis,1/60,0.002999951725986,0.004685646776936,0,0,19940.0,115834.63209072244,UGT1A6
897,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.004685646776936,0,0,19933.0,113594.38808369274,UGT1A6
898,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.004685646776936,0,0,19926.0,111574.38983110404,UGT1A6
899,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.004685646776936,0,0,19918.0,109484.9180722932,UGT1A6
900,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,UGT1A6
901,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF736
902,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0046999178784763,0,0,19953.0,120782.64067395544,PLD3
903,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,PLD3
904,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,CDC5L
905,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR14K1
906,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0069998932593308,0,0,19951.0,119939.1172087114,LHCGR
907,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0069998932593308,0,0,19930.0,112704.30065625212,LHCGR
908,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.01253320316018,0,0,19812.0,92463.712994847,LHCGR
909,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,LHCGR
910,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0220497462053947,0,0,19853.0,97539.10874372096,HEYL
911,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0247498011884467,0,0,19670.0,80733.60565076157,HEYL
912,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HEYL
913,KEGG_2019_Human,Collecting duct acid secretion,1/27,0.0013499718942362,0.0013499718942362,0,0,19973.0,131975.02298599784,SLC12A7
914,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0063999221281459,0,0,19898.0,105032.15064717118,ATG13
915,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG13
916,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0096248581368756,0,0,19926.0,111574.38983110404,CANX
917,KEGG_2019_Human,Antigen processing and presentation,1/77,0.0038499432547502,0.0096248581368756,0,0,19923.0,110765.8407373636,CANX
918,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0103123868191847,0,0,19848.0,96850.665715497,CANX
919,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0103123868191847,0,0,19835.0,95159.46482222488,CANX
920,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,CANX
921,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0154998254241149,0,0,19845.0,96448.16254952336,CRHR2
922,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CRHR2
923,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,PAN3
924,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,POLI
925,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,MYB
926,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0102498845546566,0,0,19940.0,115834.63209072244,ITPR1
927,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0102498845546566,0,0,19935.0,114209.92613860144,ITPR1
928,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0102498845546566,0,0,19933.0,113594.38808369274,ITPR1
929,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0102498845546566,0,0,19931.0,112996.7391397682,ITPR1
930,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0102498845546566,0,0,19926.0,111574.38983110404,ITPR1
931,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0102498845546566,0,0,19925.0,111301.33528642564,ITPR1
932,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0102498845546566,0,0,19912.0,108045.79305232369,ITPR1
933,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0102498845546566,0,0,19910.0,107587.50385474482,ITPR1
934,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0102498845546566,0,0,19907.0,106918.54242106884,ITPR1
935,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0102498845546566,0,0,19903.0,106058.9096435903,ITPR1
936,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0102498845546566,0,0,19902.0,105849.45495286948,ITPR1
937,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0102498845546566,0,0,19902.0,105849.45495286948,ITPR1
938,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0102498845546566,0,0,19901.0,105642.09305076736,ITPR1
939,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0102498845546566,0,0,19900.0,105436.78197328727,ITPR1
940,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0102498845546566,0,0,19897.0,104832.7525292024,ITPR1
941,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0102498845546566,0,0,19896.0,104635.24941415618,ITPR1
942,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0102498845546566,0,0,19894.0,104245.78450366124,ITPR1
943,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0102498845546566,0,0,19888.0,103119.30984392198,ITPR1
944,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0102498845546566,0,0,19887.0,102937.34947211576,ITPR1
945,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0102498845546566,0,0,19886.0,102756.96431429044,ITPR1
946,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0102498845546566,0,0,19876.0,101034.04709010696,ITPR1
947,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0102498845546566,0,0,19875.0,100869.32368441945,ITPR1
948,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0102498845546566,0,0,19872.0,100382.8010329652,ITPR1
949,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0102498845546566,0,0,19869.0,99907.33811343512,ITPR1
950,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0102498845546566,0,0,19868.0,99751.22090491928,ITPR1
951,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0102498845546566,0,0,19863.0,98987.62735269018,ITPR1
952,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0102498845546566,0,0,19863.0,98987.62735269018,ITPR1
953,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0102498845546566,0,0,19857.0,98106.57763600958,ITPR1
954,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0102498845546566,0,0,19852.0,97399.60470052566,ITPR1
955,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0102498845546566,0,0,19847.0,96715.6407630817,ITPR1
956,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0102498845546566,0,0,19845.0,96448.16254952336,ITPR1
957,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0102498860569565,0,0,19840.0,95793.96509856998,ITPR1
958,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0103101826407735,0,0,19834.0,95034.82345515196,ITPR1
959,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0103101826407735,0,0,19829.0,94422.42241345016,ITPR1
960,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0104117351786222,0,0,19822.0,93593.82745769851,ITPR1
961,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0104117351786222,0,0,19814.0,92684.96451050608,ITPR1
962,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0104117351786222,0,0,19812.0,92463.712994847,ITPR1
963,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0104117351786222,0,0,19807.0,91920.47679471428,ITPR1
964,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0105652780025579,0,0,19799.0,91079.21596609056,ITPR1
965,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0108648928901912,0,0,19788.0,89974.27756224656,ITPR1
966,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0112498919790339,0,0,19775.0,88738.27077557483,ITPR1
967,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0088999053857096,0,0,19900.0,105436.78197328727,TRPV2
968,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0088999053857096,0,0,19822.0,93593.82745769851,TRPV2
969,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0068499188797651,0,0,19928.0,112131.59838572376,COP1
970,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,COP1
971,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT5
972,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0084999078692823,0,0,19868.0,99751.22090491928,MYH11
973,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYH11
974,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,CNOT2
975,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF717
976,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,VARS2
977,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0147498749536506,0,0,19768.0,88101.22480150245,NF1
978,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,NF1
979,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0120398688515903,0,0,19942.0,116522.31890946148,SOS1
980,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0120398688515903,0,0,19934.0,113899.85357353876,SOS1
981,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0120398688515903,0,0,19934.0,113899.85357353876,SOS1
982,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0120398688515903,0,0,19932.0,113293.39338050144,SOS1
983,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0120398688515903,0,0,19931.0,112996.7391397682,SOS1
984,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0120398688515903,0,0,19930.0,112704.30065625212,SOS1
985,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0120398688515903,0,0,19929.0,112415.9585341616,SOS1
986,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0120398688515903,0,0,19925.0,111301.33528642564,SOS1
987,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0120398688515903,0,0,19924.0,111031.8499691117,SOS1
988,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0120398688515903,0,0,19915.0,108752.83801948265,SOS1
989,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0120398688515903,0,0,19914.0,108514.46102290176,SOS1
990,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0120398688515903,0,0,19912.0,108045.79305232369,SOS1
991,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0120398688515903,0,0,19907.0,106918.54242106884,SOS1
992,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0120398688515903,0,0,19903.0,106058.9096435903,SOS1
993,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0120398688515903,0,0,19901.0,105642.09305076736,SOS1
994,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0120398688515903,0,0,19899.0,105233.48101229242,SOS1
995,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0120398688515903,0,0,19881.0,101877.73080211312,SOS1
996,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0120398688515903,0,0,19870.0,100064.62842845908,SOS1
997,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0120398688515903,0,0,19869.0,99907.33811343512,SOS1
998,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0120398688515903,0,0,19868.0,99751.22090491928,SOS1
999,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0120398688515903,0,0,19863.0,98987.62735269018,SOS1
1000,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0120398688515903,0,0,19863.0,98987.62735269018,SOS1
1001,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0120398688515903,0,0,19853.0,97539.10874372096,SOS1
1002,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0120398688515903,0,0,19852.0,97399.60470052566,SOS1
1003,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0120398688515903,0,0,19851.0,97261.02051561224,SOS1
1004,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0120398688515903,0,0,19848.0,96850.665715497,SOS1
1005,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0120398688515903,0,0,19845.0,96448.16254952336,SOS1
1006,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0120398688515903,0,0,19838.0,95537.86936302872,SOS1
1007,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0120398688515903,0,0,19837.0,95410.9786681514,SOS1
1008,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0120398688515903,0,0,19832.0,94787.72752807094,SOS1
1009,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0124837388808067,0,0,19820.0,93362.92821536642,SOS1
1010,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0127101658610399,0,0,19810.0,92244.74636351672,SOS1
1011,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0127101658610399,0,0,19801.0,91286.4288690606,SOS1
1012,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0127101658610399,0,0,19799.0,91079.21596609056,SOS1
1013,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0131261914685078,0,0,19786.0,89779.39753374986,SOS1
1014,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0131261914685078,0,0,19775.0,88738.27077557483,SOS1
1015,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0131261914685078,0,0,19769.0,88191.07730937863,SOS1
1016,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0131261914685078,0,0,19768.0,88101.22480150245,SOS1
1017,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0160711146220803,0,0,19705.0,83086.53988020132,SOS1
1018,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0160711146220803,0,0,19701.0,82804.33538735632,SOS1
1019,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0173047390423286,0,0,19670.0,80733.60565076157,SOS1
1020,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0181212879423518,0,0,19646.0,79255.8617626126,SOS1
1021,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,SOS1
1022,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0111598835581629,0,0,19924.0,111031.8499691117,TICAM1
1023,KEGG_2019_Human,NF-kappa B signaling pathway,1/95,0.0047499351803394,0.0111598835581629,0,0,19905.0,106484.27183626965,TICAM1
1024,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0111598835581629,0,0,19897.0,104832.7525292024,TICAM1
1025,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0111598835581629,0,0,19896.0,104635.24941415618,TICAM1
1026,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0111598835581629,0,0,19845.0,96448.16254952336,TICAM1
1027,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0111598835581629,0,0,19838.0,95537.86936302872,TICAM1
1028,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0111598835581629,0,0,19837.0,95410.9786681514,TICAM1
1029,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0111598835581629,0,0,19829.0,94422.42241345016,TICAM1
1030,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0111598835581629,0,0,19822.0,93593.82745769851,TICAM1
1031,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0111598835581629,0,0,19814.0,92684.96451050608,TICAM1
1032,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0179998554097794,0,0,19670.0,80733.60565076157,TICAM1
1033,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,TICAM1
1034,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0092999029651357,0,0,19868.0,99751.22090491928,BCL6
1035,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,BCL6
1036,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0072499160871101,0,0,19855.0,97820.92670675044,PVR
1037,KEGG_2019_Human,Inflammatory bowel disease (IBD),1/65,0.003249949134407,0.0053499302026925,0,0,19935.0,114209.92613860144,FOXP3
1038,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0053499302026925,0,0,19893.0,104053.753408911,FOXP3
1039,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0047832644181221,0,0,19964.0,126172.23364250171,ADH1B
1040,KEGG_2019_Human,Fatty acid degradation,1/44,0.0021999607179423,0.0047832644181221,0,0,19956.0,122117.06559109331,ADH1B
1041,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0047832644181221,0,0,19933.0,113594.38808369274,ADH1B
1042,KEGG_2019_Human,Glycolysis / Gluconeogenesis,1/68,0.0033999476216189,0.0047832644181221,0,0,19932.0,113293.39338050144,ADH1B
1043,KEGG_2019_Human,Metabolism of xenobiotics by cytochrome P450,1/74,0.0036999446830449,0.0047832644181221,0,0,19926.0,111574.38983110404,ADH1B
1044,KEGG_2019_Human,Chemical carcinogenesis,1/82,0.004099940929819,0.0047832644181221,0,0,19918.0,109484.9180722932,ADH1B
1045,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,ADH1B
1046,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF169
1047,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6C2
1048,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,ATG2A
1049,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,MGAT2
1050,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0121998870519305,0,0,19863.0,98987.62735269018,WWP1
1051,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,WWP1
1052,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0050499326546803,0,0,19921.0,110243.89578070649,XRN1
1053,KEGG_2019_Human,Ribosome biogenesis in eukaryotes,1/101,0.0050499326546803,0.0050499326546803,0,0,19899.0,105233.48101229242,XRN1
1054,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF671
1055,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52N1
1056,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF114
1057,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,SEMA4G
1058,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,CGNL1
1059,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,SRPK1
1060,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0160498424271101,0,0,19888.0,103119.30984392198,CHRM1
1061,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0160498424271101,0,0,19812.0,92463.712994847,CHRM1
1062,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0160498424271101,0,0,19788.0,89974.27756224656,CHRM1
1063,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0160498424271101,0,0,19786.0,89779.39753374986,CHRM1
1064,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0176998626413668,0,0,19662.0,80229.79996326564,CHRM1
1065,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,CHRM1
1066,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.009399902370135,0,0,19910.0,107587.50385474482,RYR3
1067,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.009399902370135,0,0,19903.0,106058.9096435903,RYR3
1068,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.009399902370135,0,0,19863.0,98987.62735269018,RYR3
1069,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.009399902370135,0,0,19847.0,96715.6407630817,RYR3
1070,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.009399902370135,0,0,19829.0,94422.42241345016,RYR3
1071,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.009399902370135,0,0,19812.0,92463.712994847,RYR3
1072,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0146398644623166,0,0,19840.0,95793.96509856998,PARD6B
1073,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0146398644623166,0,0,19830.0,94543.49009679438,PARD6B
1074,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0146398644623166,0,0,19819.0,93248.41634586031,PARD6B
1075,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0146398644623166,0,0,19794.0,90569.849337325,PARD6B
1076,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0146398644623166,0,0,19756.0,87051.4275316661,PARD6B
1077,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,PARD6B
1078,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0064284853770715,0,0,19975.0,133525.54486996148,PLA2G6
1079,KEGG_2019_Human,Linoleic acid metabolism,1/29,0.001449970461791,0.0064284853770715,0,0,19971.0,130534.69172799008,PLA2G6
1080,KEGG_2019_Human,Ether lipid metabolism,1/47,0.0023499589392381,0.0064284853770715,0,0,19953.0,120782.64067395544,PLA2G6
1081,KEGG_2019_Human,Arachidonic acid metabolism,1/63,0.0031499501598827,0.0064284853770715,0,0,19937.0,114844.46974572667,PLA2G6
1082,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0064284853770715,0,0,19909.0,107362.10783923086,PLA2G6
1083,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0064284853770715,0,0,19903.0,106058.9096435903,PLA2G6
1084,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0064284853770715,0,0,19900.0,105436.78197328727,PLA2G6
1085,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0074249107536368,0,0,19868.0,99751.22090491928,PLA2G6
1086,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,PLA2G6
1087,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0147498749536506,0,0,19840.0,95793.96509856998,STK3
1088,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,STK3
1089,KEGG_2019_Human,Bacterial invasion of epithelial cells,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,ARHGAP10
1090,KEGG_2019_Human,Galactose metabolism,1/31,0.0015499690656704,0.0021999607179423,0,0,19969.0,129189.85098816035,SI
1091,KEGG_2019_Human,Starch and sucrose metabolism,1/36,0.0017999657178272,0.0021999607179423,0,0,19964.0,126172.23364250171,SI
1092,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0021999607179423,0,0,19956.0,122117.06559109331,SI
1093,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR6M1
1094,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0115998533024171,0,0,19884.0,102400.8105961506,THRB
1095,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,THRB
1096,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,USP39
1097,KEGG_2019_Human,Vitamin digestion and absorption,1/24,0.0011999741185782,0.0024999572069037,0,0,19976.0,134347.69487847842,APOB
1098,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0024999572069037,0,0,19959.0,123544.88783416104,APOB
1099,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,APOB
1100,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,HOXA10
1101,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0115498903940656,0,0,19832.0,94787.72752807094,DPF3
1102,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,DPF3
1103,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0065832371945562,0,0,19932.0,113293.39338050144,C1R
1104,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0065832371945562,0,0,19924.0,111031.8499691117,C1R
1105,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0065832371945562,0,0,19921.0,110243.89578070649,C1R
1106,KEGG_2019_Human,Systemic lupus erythematosus,1/133,0.0066499203093911,0.0075999137114971,0,0,19867.0,99596.2591544721,C1R
1107,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,C1R
1108,KEGG_2019_Human,Glycosphingolipid biosynthesis,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,B3GALT1
1109,KEGG_2019_Human,"Glycine, serine and threonine metabolism",1/40,0.0019999631680592,0.0019999631680592,0,0,19960.0,124043.94523066044,GCAT
1110,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0029499522555206,0,0,19970.0,129851.13732048514,DLST
1111,KEGG_2019_Human,Tryptophan metabolism,1/42,0.0020999619311272,0.0029499522555206,0,0,19958.0,123057.75613441122,DLST
1112,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,DLST
1113,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0111598835581629,0,0,19941.0,116175.59385530632,NFATC2
1114,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0111598835581629,0,0,19929.0,112415.9585341616,NFATC2
1115,KEGG_2019_Human,Th1 and Th2 cell differentiation,1/92,0.0045999364719865,0.0111598835581629,0,0,19908.0,107139.13814408927,NFATC2
1116,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0111598835581629,0,0,19899.0,105233.48101229242,NFATC2
1117,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0111598835581629,0,0,19896.0,104635.24941415618,NFATC2
1118,KEGG_2019_Human,Th17 cell differentiation,1/107,0.0053499302026925,0.0111598835581629,0,0,19893.0,104053.753408911,NFATC2
1119,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0111598835581629,0,0,19873.0,100543.72072014232,NFATC2
1120,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0111598835581629,0,0,19869.0,99907.33811343512,NFATC2
1121,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0111598835581629,0,0,19847.0,96715.6407630817,NFATC2
1122,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0111598835581629,0,0,19842.0,96053.2110949472,NFATC2
1123,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0111598835581629,0,0,19840.0,95793.96509856998,NFATC2
1124,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0111598835581629,0,0,19837.0,95410.9786681514,NFATC2
1125,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0111598835581629,0,0,19834.0,95034.82345515196,NFATC2
1126,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0111598835581629,0,0,19819.0,93248.41634586031,NFATC2
1127,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0111598835581629,0,0,19814.0,92684.96451050608,NFATC2
1128,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0112498919790339,0,0,19788.0,89974.27756224656,NFATC2
1129,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0112498919790339,0,0,19781.0,89299.85161916987,NFATC2
1130,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0112498919790339,0,0,19775.0,88738.27077557483,NFATC2
1131,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT6
1132,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR10K1
1133,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0115998901349604,0,0,19768.0,88101.22480150245,KSR2
1134,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,EDC4
1135,KEGG_2019_Human,Pathogenic Escherichia coli infection,1/55,0.0027499544131125,0.0124832107766412,0,0,19945.0,117599.1294878737,EZR
1136,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0124832107766412,0,0,19925.0,111301.33528642564,EZR
1137,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0124832107766412,0,0,19888.0,103119.30984392198,EZR
1138,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0124832107766412,0,0,19830.0,94543.49009679438,EZR
1139,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0124832107766412,0,0,19799.0,91079.21596609056,EZR
1140,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0124832107766412,0,0,19786.0,89779.39753374986,EZR
1141,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.0149498740670514,0.0149498740670514,0,0,19701.0,82804.33538735632,EZR
1142,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,DERA
1143,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0048499343304706,0,0,19903.0,106058.9096435903,TAZ
1144,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0073998893660899,0,0,19945.0,117599.1294878737,PLIN1
1145,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0073998893660899,0,0,19926.0,111574.38983110404,PLIN1
1146,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0091332251730202,0,0,19863.0,98987.62735269018,PLIN1
1147,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,PLIN1
1148,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,ADGRB1
1149,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,PLCH1
1150,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0022999497639899,0,0,19977.0,135204.63922267244,KLK2
1151,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,KLK2
1152,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR9K2
1153,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,POU2F1
1154,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYH4
1155,KEGG_2019_Human,Protein digestion and absorption,1/90,0.0044999373439762,0.0044999373439762,0,0,19910.0,107587.50385474482,COL12A1
1156,KEGG_2019_Human,TGF-beta signaling pathway,1/90,0.0044999373439762,0.010424877259224,0,0,19910.0,107587.50385474482,NODAL
1157,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.010424877259224,0,0,19861.0,98689.81333375497,NODAL
1158,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,NODAL
1159,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,LTB4R
1160,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0013999711732997,0,0,19972.0,131242.0761597353,RCVRN
1161,KEGG_2019_Human,Vasopressin-regulated water reabsorption,1/44,0.0021999607179423,0.0093396383965821,0,0,19956.0,122117.06559109331,ADCY6
1162,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0093396383965821,0,0,19952.0,120356.5272753826,ADCY6
1163,KEGG_2019_Human,Ovarian steroidogenesis,1/49,0.0024499577795033,0.0093396383965821,0,0,19951.0,119939.1172087114,ADCY6
1164,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0093396383965821,0,0,19945.0,117599.1294878737,ADCY6
1165,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0093396383965821,0,0,19935.0,114209.92613860144,ADCY6
1166,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0093396383965821,0,0,19931.0,112996.7391397682,ADCY6
1167,KEGG_2019_Human,Bile secretion,1/72,0.0035999456502131,0.0093396383965821,0,0,19928.0,112131.59838572376,ADCY6
1168,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0093396383965821,0,0,19926.0,111574.38983110404,ADCY6
1169,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0093396383965821,0,0,19925.0,111301.33528642564,ADCY6
1170,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0093396383965821,0,0,19917.0,109237.99888847338,ADCY6
1171,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0093396383965821,0,0,19914.0,108514.46102290176,ADCY6
1172,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0093396383965821,0,0,19912.0,108045.79305232369,ADCY6
1173,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0093396383965821,0,0,19911.0,107815.380281759,ADCY6
1174,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0093396383965821,0,0,19910.0,107587.50385474482,ADCY6
1175,KEGG_2019_Human,Dilated cardiomyopathy (DCM),1/91,0.0045499369072032,0.0093396383965821,0,0,19909.0,107362.10783923086,ADCY6
1176,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0093396383965821,0,0,19909.0,107362.10783923086,ADCY6
1177,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0093396383965821,0,0,19907.0,106918.54242106884,ADCY6
1178,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0093396383965821,0,0,19903.0,106058.9096435903,ADCY6
1179,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0093396383965821,0,0,19902.0,105849.45495286948,ADCY6
1180,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0093396383965821,0,0,19902.0,105849.45495286948,ADCY6
1181,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0093396383965821,0,0,19901.0,105642.09305076736,ADCY6
1182,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0093396383965821,0,0,19900.0,105436.78197328727,ADCY6
1183,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0093396383965821,0,0,19899.0,105233.48101229242,ADCY6
1184,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0093396383965821,0,0,19898.0,105032.15064717118,ADCY6
1185,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0093396383965821,0,0,19894.0,104245.78450366124,ADCY6
1186,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0093396383965821,0,0,19888.0,103119.30984392198,ADCY6
1187,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0093396383965821,0,0,19886.0,102756.96431429044,ADCY6
1188,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0093396383965821,0,0,19876.0,101034.04709010696,ADCY6
1189,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0093396383965821,0,0,19875.0,100869.32368441945,ADCY6
1190,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.0093396383965821,0,0,19871.0,100223.109907462,ADCY6
1191,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0093396383965821,0,0,19870.0,100064.62842845908,ADCY6
1192,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0093396383965821,0,0,19868.0,99751.22090491928,ADCY6
1193,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0093396383965821,0,0,19863.0,98987.62735269018,ADCY6
1194,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0093396383965821,0,0,19863.0,98987.62735269018,ADCY6
1195,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0093396383965821,0,0,19855.0,97820.92670675044,ADCY6
1196,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0093396383965821,0,0,19852.0,97399.60470052566,ADCY6
1197,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0093396383965821,0,0,19852.0,97399.60470052566,ADCY6
1198,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0093396383965821,0,0,19847.0,96715.6407630817,ADCY6
1199,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0093396383965821,0,0,19845.0,96448.16254952336,ADCY6
1200,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0097523932352386,0,0,19834.0,95034.82345515196,ADCY6
1201,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0108901313078629,0,0,19810.0,92244.74636351672,ADCY6
1202,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0115260754085087,0,0,19794.0,90569.849337325,ADCY6
1203,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0115859322935675,0,0,19788.0,89974.27756224656,ADCY6
1204,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0116964772432401,0,0,19781.0,89299.85161916987,ADCY6
1205,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.011749887178102,0,0,19775.0,88738.27077557483,ADCY6
1206,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0118009749678496,0,0,19769.0,88191.07730937863,ADCY6
1207,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ADCY6
1208,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0092999029651357,0,0,19928.0,112131.59838572376,IGFBP3
1209,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0092999029651357,0,0,19840.0,95793.96509856998,IGFBP3
1210,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0092999029651357,0,0,19814.0,92684.96451050608,IGFBP3
1211,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0082499094553477,0,0,19909.0,107362.10783923086,UPF3B
1212,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UPF3B
1213,KEGG_2019_Human,Other types of O-glycan biosynthesis,1/22,0.0010999756574123,0.003299926972237,0,0,19978.0,136099.47030191717,LFNG
1214,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0035999375351982,0,0,19952.0,120356.5272753826,LFNG
1215,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,LFNG
1216,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0146998751759735,0,0,19706.0,83157.67014793828,ACVRL1
1217,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0221998465247771,0,0,19556.0,74462.79263140135,OR52E2
1218,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,KMT5B
1219,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0127498618039235,0,0,19840.0,95793.96509856998,MPP5
1220,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0127498618039235,0,0,19830.0,94543.49009679438,MPP5
1221,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0164998674589645,0,0,19670.0,80733.60565076157,MPP5
1222,KEGG_2019_Human,Carbohydrate digestion and absorption,1/44,0.0021999607179423,0.0107174211792485,0,0,19956.0,122117.06559109331,AKT2
1223,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0027499544131125,0.0107174211792485,0,0,19945.0,117599.1294878737,AKT2
1224,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0107174211792485,0,0,19942.0,116522.31890946148,AKT2
1225,KEGG_2019_Human,VEGF signaling pathway,1/59,0.0029499522555206,0.0107174211792485,0,0,19941.0,116175.59385530632,AKT2
1226,KEGG_2019_Human,Central carbon metabolism in cancer,1/65,0.003249949134407,0.0107174211792485,0,0,19935.0,114209.92613860144,AKT2
1227,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0107174211792485,0,0,19934.0,113899.85357353876,AKT2
1228,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.0107174211792485,0,0,19934.0,113899.85357353876,AKT2
1229,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0107174211792485,0,0,19932.0,113293.39338050144,AKT2
1230,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0107174211792485,0,0,19931.0,112996.7391397682,AKT2
1231,KEGG_2019_Human,Renal cell carcinoma,1/69,0.003449947123837,0.0107174211792485,0,0,19931.0,112996.7391397682,AKT2
1232,KEGG_2019_Human,Prolactin signaling pathway,1/70,0.0034999466296654,0.0107174211792485,0,0,19930.0,112704.30065625212,AKT2
1233,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0107174211792485,0,0,19929.0,112415.9585341616,AKT2
1234,KEGG_2019_Human,Melanoma,1/72,0.0035999456502131,0.0107174211792485,0,0,19928.0,112131.59838572376,AKT2
1235,KEGG_2019_Human,Pancreatic cancer,1/75,0.0037499442041125,0.0107174211792485,0,0,19925.0,111301.33528642564,AKT2
1236,KEGG_2019_Human,Glioma,1/75,0.0037499442041125,0.0107174211792485,0,0,19925.0,111301.33528642564,AKT2
1237,KEGG_2019_Human,Chronic myeloid leukemia,1/76,0.0037999437281752,0.0107174211792485,0,0,19924.0,111031.8499691117,AKT2
1238,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0107174211792485,0,0,19915.0,108752.83801948265,AKT2
1239,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0107174211792485,0,0,19914.0,108514.46102290176,AKT2
1240,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,1/91,0.0045499369072032,0.0107174211792485,0,0,19909.0,107362.10783923086,AKT2
1241,KEGG_2019_Human,Small cell lung cancer,1/93,0.0046499360391879,0.0107174211792485,0,0,19907.0,106918.54242106884,AKT2
1242,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0107174211792485,0,0,19903.0,106058.9096435903,AKT2
1243,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0107174211792485,0,0,19901.0,105642.09305076736,AKT2
1244,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0107174211792485,0,0,19901.0,105642.09305076736,AKT2
1245,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.0049999330710556,0.0107174211792485,0,0,19900.0,105436.78197328727,AKT2
1246,KEGG_2019_Human,HIF-1 signaling pathway,1/100,0.0049999330710556,0.0107174211792485,0,0,19900.0,105436.78197328727,AKT2
1247,KEGG_2019_Human,T cell receptor signaling pathway,1/101,0.0050499326546803,0.0107174211792485,0,0,19899.0,105233.48101229242,AKT2
1248,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0107174211792485,0,0,19898.0,105032.15064717118,AKT2
1249,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0107174211792485,0,0,19897.0,104832.7525292024,AKT2
1250,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0107174211792485,0,0,19897.0,104832.7525292024,AKT2
1251,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0107174211792485,0,0,19896.0,104635.24941415618,AKT2
1252,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0107174211792485,0,0,19896.0,104635.24941415618,AKT2
1253,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0107174211792485,0,0,19892.0,103863.47861844616,AKT2
1254,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0107174211792485,0,0,19890.0,103488.06969787036,AKT2
1255,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0107174211792485,0,0,19888.0,103119.30984392198,AKT2
1256,KEGG_2019_Human,Toxoplasmosis,1/113,0.0056499278191151,0.0107174211792485,0,0,19887.0,102937.34947211576,AKT2
1257,KEGG_2019_Human,Thyroid hormone signaling pathway,1/116,0.0057999266512085,0.0107174211792485,0,0,19884.0,102400.8105961506,AKT2
1258,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.0059499254985137,0.0107174211792485,0,0,19881.0,101877.73080211312,AKT2
1259,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0107174211792485,0,0,19881.0,101877.73080211312,AKT2
1260,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0107174211792485,0,0,19880.0,101706.2448082016,AKT2
1261,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0107174211792485,0,0,19876.0,101034.04709010696,AKT2
1262,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0107174211792485,0,0,19873.0,100543.72072014232,AKT2
1263,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0107174211792485,0,0,19872.0,100382.8010329652,AKT2
1264,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0107174211792485,0,0,19870.0,100064.62842845908,AKT2
1265,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0107174211792485,0,0,19869.0,99907.33811343512,AKT2
1266,KEGG_2019_Human,FoxO signaling pathway,1/132,0.0065999206698993,0.0107174211792485,0,0,19868.0,99751.22090491928,AKT2
1267,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0107174211792485,0,0,19863.0,98987.62735269018,AKT2
1268,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0107174211792485,0,0,19863.0,98987.62735269018,AKT2
1269,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0107174211792485,0,0,19863.0,98987.62735269018,AKT2
1270,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0107174211792485,0,0,19862.0,98838.19160389496,AKT2
1271,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0107174211792485,0,0,19861.0,98689.81333375497,AKT2
1272,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0107174211792485,0,0,19861.0,98689.81333375497,AKT2
1273,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0107174211792485,0,0,19857.0,98106.57763600958,AKT2
1274,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0107174211792485,0,0,19855.0,97820.92670675044,AKT2
1275,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0107174211792485,0,0,19853.0,97539.10874372096,AKT2
1276,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.0107174211792485,0,0,19852.0,97399.60470052566,AKT2
1277,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0107174211792485,0,0,19851.0,97261.02051561224,AKT2
1278,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0107174211792485,0,0,19851.0,97261.02051561224,AKT2
1279,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0107447055921166,0,0,19848.0,96850.665715497,AKT2
1280,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0107623827670465,0,0,19845.0,96448.16254952336,AKT2
1281,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0107623827670465,0,0,19840.0,95793.96509856998,AKT2
1282,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0107623827670465,0,0,19838.0,95537.86936302872,AKT2
1283,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0107623827670465,0,0,19837.0,95410.9786681514,AKT2
1284,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0107623827670465,0,0,19834.0,95034.82345515196,AKT2
1285,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0107623827670465,0,0,19832.0,94787.72752807094,AKT2
1286,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0107860372241938,0,0,19829.0,94422.42241345016,AKT2
1287,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0111195790388576,0,0,19821.0,93478.0629355712,AKT2
1288,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0113819707931512,0,0,19814.0,92684.96451050608,AKT2
1289,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0114557639102112,0,0,19810.0,92244.74636351672,AKT2
1290,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0116069251295706,0,0,19801.0,91286.4288690606,AKT2
1291,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0116069251295706,0,0,19799.0,91079.21596609056,AKT2
1292,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0116069251295706,0,0,19799.0,91079.21596609056,AKT2
1293,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0117304384476667,0,0,19794.0,90569.849337325,AKT2
1294,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.011745830151558,0,0,19788.0,89974.27756224656,AKT2
1295,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.011745830151558,0,0,19788.0,89974.27756224656,AKT2
1296,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0119718836577617,0,0,19781.0,89299.85161916987,AKT2
1297,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0121380413457997,0,0,19775.0,88738.27077557483,AKT2
1298,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0123531297541136,0,0,19768.0,88101.22480150245,AKT2
1299,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0155062787974276,0,0,19705.0,83086.53988020132,AKT2
1300,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0171264447042416,0,0,19670.0,80733.60565076157,AKT2
1301,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.018142359207401,0,0,19646.0,79255.8617626126,AKT2
1302,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0249035406954225,0,0,19508.0,72277.44006442746,AKT2
1303,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,AKT2
1304,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0082999091363732,0,0,19914.0,108514.46102290176,KCNMB3
1305,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0082999091363732,0,0,19868.0,99751.22090491928,KCNMB3
1306,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0082999091363732,0,0,19834.0,95034.82345515196,KCNMB3
1307,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,RBKS
1308,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0112348896989771,0,0,19933.0,113594.38808369274,PPP1CA
1309,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0112348896989771,0,0,19932.0,113293.39338050144,PPP1CA
1310,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0112348896989771,0,0,19909.0,107362.10783923086,PPP1CA
1311,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0112348896989771,0,0,19900.0,105436.78197328727,PPP1CA
1312,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0112348896989771,0,0,19892.0,103863.47861844616,PPP1CA
1313,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0112348896989771,0,0,19876.0,101034.04709010696,PPP1CA
1314,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0112348896989771,0,0,19875.0,100869.32368441945,PPP1CA
1315,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0112348896989771,0,0,19869.0,99907.33811343512,PPP1CA
1316,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0112348896989771,0,0,19868.0,99751.22090491928,PPP1CA
1317,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0112348896989771,0,0,19863.0,98987.62735269018,PPP1CA
1318,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0112348896989771,0,0,19855.0,97820.92670675044,PPP1CA
1319,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0112348896989771,0,0,19847.0,96715.6407630817,PPP1CA
1320,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0112348896989771,0,0,19840.0,95793.96509856998,PPP1CA
1321,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0112348896989771,0,0,19840.0,95793.96509856998,PPP1CA
1322,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0112348896989771,0,0,19834.0,95034.82345515196,PPP1CA
1323,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0112348896989771,0,0,19820.0,93362.92821536642,PPP1CA
1324,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0112348896989771,0,0,19801.0,91286.4288690606,PPP1CA
1325,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0112348896989771,0,0,19799.0,91079.21596609056,PPP1CA
1326,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0112348896989771,0,0,19788.0,89974.27756224656,PPP1CA
1327,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0112348896989771,0,0,19786.0,89779.39753374986,PPP1CA
1328,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,PPP1CA
1329,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,CRB2
1330,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,MOB1B
1331,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.006599897253216,0,0,19934.0,113899.85357353876,ALK
1332,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,ALK
1333,KEGG_2019_Human,N-Glycan biosynthesis,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,MGAT3
1334,KEGG_2019_Human,Insulin resistance,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,OGA
1335,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.0079999110688441,0,0,19840.0,95793.96509856998,ZFP36L1
1336,KEGG_2019_Human,Neurotrophin signaling pathway,1/119,0.0059499254985137,0.0068499188797651,0,0,19881.0,101877.73080211312,SH2B2
1337,KEGG_2019_Human,Insulin signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,SH2B2
1338,KEGG_2019_Human,Retinol metabolism,1/67,0.0033499481224912,0.0033499481224912,0,0,19933.0,113594.38808369274,RDH8
1339,KEGG_2019_Human,Malaria,1/49,0.0024499577795033,0.0095998695077413,0,0,19951.0,119939.1172087114,ITGB2
1340,KEGG_2019_Human,Legionellosis,1/55,0.0027499544131125,0.0095998695077413,0,0,19945.0,117599.1294878737,ITGB2
1341,KEGG_2019_Human,Viral myocarditis,1/59,0.0029499522555206,0.0095998695077413,0,0,19941.0,116175.59385530632,ITGB2
1342,KEGG_2019_Human,Staphylococcus aureus infection,1/68,0.0033999476216189,0.0095998695077413,0,0,19932.0,113293.39338050144,ITGB2
1343,KEGG_2019_Human,Leishmaniasis,1/74,0.0036999446830449,0.0095998695077413,0,0,19926.0,111574.38983110404,ITGB2
1344,KEGG_2019_Human,Pertussis,1/76,0.0037999437281752,0.0095998695077413,0,0,19924.0,111031.8499691117,ITGB2
1345,KEGG_2019_Human,Complement and coagulation cascades,1/79,0.0039499423167337,0.0095998695077413,0,0,19921.0,110243.89578070649,ITGB2
1346,KEGG_2019_Human,Rheumatoid arthritis,1/91,0.0045499369072032,0.0095998695077413,0,0,19909.0,107362.10783923086,ITGB2
1347,KEGG_2019_Human,Amoebiasis,1/96,0.0047999347538706,0.0095998695077413,0,0,19904.0,106270.50039849174,ITGB2
1348,KEGG_2019_Human,Leukocyte transendothelial migration,1/112,0.0055999282120529,0.0100798707816953,0,0,19888.0,103119.30984392198,ITGB2
1349,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0102855999456567,0,0,19869.0,99907.33811343512,ITGB2
1350,KEGG_2019_Human,Cell adhesion molecules (CAMs),1/145,0.0072499160871101,0.0102855999456567,0,0,19855.0,97820.92670675044,ITGB2
1351,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0102855999456567,0,0,19848.0,96850.665715497,ITGB2
1352,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0102855999456567,0,0,19840.0,95793.96509856998,ITGB2
1353,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0107398860960673,0,0,19821.0,93478.0629355712,ITGB2
1354,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0109498935894162,0,0,19794.0,90569.849337325,ITGB2
1355,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0109498935894162,0,0,19786.0,89779.39753374986,ITGB2
1356,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,ITGB2
1357,KEGG_2019_Human,B cell receptor signaling pathway,1/71,0.0035499461386618,0.0070998922773237,0,0,19929.0,112415.9585341616,PIK3AP1
1358,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,PIK3AP1
1359,KEGG_2019_Human,Amino sugar and nucleotide sugar metabolism,1/48,0.0023999583567988,0.0023999583567988,0,0,19952.0,120356.5272753826,UXS1
1360,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,REV1
1361,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0095998334271952,0,0,19952.0,120356.5272753826,SNW1
1362,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0100498985877989,0,0,19866.0,99442.43560916925,SNW1
1363,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,SNW1
1364,KEGG_2019_Human,Viral carcinogenesis,1/201,0.0100498985877989,0.0100498985877989,0,0,19799.0,91079.21596609056,SNW1
1365,KEGG_2019_Human,Phagosome,1/152,0.0075999137114971,0.0075999137114971,0,0,19848.0,96850.665715497,MSR1
1366,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,SYNJ2
1367,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,SYNJ2
1368,KEGG_2019_Human,GABAergic synapse,1/89,0.0044499377838098,0.0137748695352654,0,0,19911.0,107815.380281759,GNG7
1369,KEGG_2019_Human,Morphine addiction,1/91,0.0045499369072032,0.0137748695352654,0,0,19909.0,107362.10783923086,GNG7
1370,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0137748695352654,0,0,19903.0,106058.9096435903,GNG7
1371,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0137748695352654,0,0,19888.0,103119.30984392198,GNG7
1372,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0137748695352654,0,0,19887.0,102937.34947211576,GNG7
1373,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0137748695352654,0,0,19886.0,102756.96431429044,GNG7
1374,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0137748695352654,0,0,19870.0,100064.62842845908,GNG7
1375,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0137748695352654,0,0,19869.0,99907.33811343512,GNG7
1376,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0137748695352654,0,0,19863.0,98987.62735269018,GNG7
1377,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0137748695352654,0,0,19852.0,97399.60470052566,GNG7
1378,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0137748695352654,0,0,19820.0,93362.92821536642,GNG7
1379,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0137748695352654,0,0,19814.0,92684.96451050608,GNG7
1380,KEGG_2019_Human,Chemokine signaling pathway,1/190,0.0094999017791995,0.0137748695352654,0,0,19810.0,92244.74636351672,GNG7
1381,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0137748695352654,0,0,19788.0,89974.27756224656,GNG7
1382,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0137748695352654,0,0,19775.0,88738.27077557483,GNG7
1383,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0137748695352654,0,0,19768.0,88101.22480150245,GNG7
1384,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0197821994227041,0,0,19646.0,79255.8617626126,GNG7
1385,KEGG_2019_Human,Olfactory transduction,1/444,0.0221998465247771,0.0234331713317091,0,0,19556.0,74462.79263140135,GNG7
1386,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,GNG7
1387,KEGG_2019_Human,Pyrimidine metabolism,1/57,0.002849953326298,0.0053999298011749,0,0,19943.0,116875.00742975442,TK1
1388,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,TK1
1389,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0030499512001654,0,0,19950.0,119530.05920663515,LIPC
1390,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0030499512001654,0,0,19939.0,115499.24335773686,LIPC
1391,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KLHL13
1392,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,1/68,0.0033999476216189,0.0115831969546933,0,0,19932.0,113293.39338050144,MAP2K4
1393,KEGG_2019_Human,Fc epsilon RI signaling pathway,1/68,0.0033999476216189,0.0115831969546933,0,0,19932.0,113293.39338050144,MAP2K4
1394,KEGG_2019_Human,ErbB signaling pathway,1/85,0.004249939567045,0.0115831969546933,0,0,19915.0,108752.83801948265,MAP2K4
1395,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0115831969546933,0,0,19907.0,106918.54242106884,MAP2K4
1396,KEGG_2019_Human,Chagas disease (American trypanosomiasis),1/103,0.0051499318302617,0.0115831969546933,0,0,19897.0,104832.7525292024,MAP2K4
1397,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0115831969546933,0,0,19896.0,104635.24941415618,MAP2K4
1398,KEGG_2019_Human,TNF signaling pathway,1/110,0.0054999290027479,0.0115831969546933,0,0,19890.0,103488.06969787036,MAP2K4
1399,KEGG_2019_Human,Relaxin signaling pathway,1/130,0.0064999213952527,0.0115831969546933,0,0,19870.0,100064.62842845908,MAP2K4
1400,KEGG_2019_Human,Fluid shear stress and atherosclerosis,1/139,0.006949918172816,0.0115831969546933,0,0,19861.0,98689.81333375497,MAP2K4
1401,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0115960368320757,0,0,19837.0,95410.9786681514,MAP2K4
1402,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0115960368320757,0,0,19829.0,94422.42241345016,MAP2K4
1403,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0115960368320757,0,0,19814.0,92684.96451050608,MAP2K4
1404,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0115960368320757,0,0,19799.0,91079.21596609056,MAP2K4
1405,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0117320288458031,0,0,19781.0,89299.85161916987,MAP2K4
1406,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP2K4
1407,KEGG_2019_Human,Protein processing in endoplasmic reticulum,1/165,0.0082499094553477,0.0082499094553477,0,0,19835.0,95159.46482222488,UGGT2
1408,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0109198810514423,0,0,19937.0,114844.46974572667,FZD5
1409,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0109198810514423,0,0,19899.0,105233.48101229242,FZD5
1410,KEGG_2019_Human,Signaling pathways regulating pluripotency of stem cells,1/139,0.006949918172816,0.0109198810514423,0,0,19861.0,98689.81333375497,FZD5
1411,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0109198810514423,0,0,19853.0,97539.10874372096,FZD5
1412,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0109198810514423,0,0,19851.0,97261.02051561224,FZD5
1413,KEGG_2019_Human,mTOR signaling pathway,1/152,0.0075999137114971,0.0109198810514423,0,0,19848.0,96850.665715497,FZD5
1414,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0109198810514423,0,0,19845.0,96448.16254952336,FZD5
1415,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0109198810514423,0,0,19842.0,96053.2110949472,FZD5
1416,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0109198810514423,0,0,19840.0,95793.96509856998,FZD5
1417,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0109198810514423,0,0,19832.0,94787.72752807094,FZD5
1418,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0118771528764897,0,0,19799.0,91079.21596609056,FZD5
1419,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0178748564138782,0,0,19670.0,80733.60565076157,FZD5
1420,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,FZD5
1421,KEGG_2019_Human,Mucin type O-glycan biosynthesis,1/31,0.0015499690656704,0.0015499690656704,0,0,19969.0,129189.85098816035,GALNT9
1422,KEGG_2019_Human,Maturity onset diabetes of the young,1/26,0.0012999726251831,0.0062998949133314,0,0,19974.0,132735.46073187632,HES1
1423,KEGG_2019_Human,Notch signaling pathway,1/48,0.0023999583567988,0.0062998949133314,0,0,19952.0,120356.5272753826,HES1
1424,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0062998949133314,0,0,19946.0,117971.01964061816,HES1
1425,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0128623519531469,0,0,19853.0,97539.10874372096,HES1
1426,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0140698580229185,0,0,19799.0,91079.21596609056,HES1
1427,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0192498453687919,0,0,19670.0,80733.60565076157,HES1
1428,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,HES1
1429,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYH8
1430,KEGG_2019_Human,Vitamin B6 metabolism,1/6,0.0002999905873105514,0.0002999905873105514,0,0,19994.0,162186.51863187927,PNPO
1431,KEGG_2019_Human,Synaptic vesicle cycle,1/78,0.0038999427840466,0.0038999427840466,0,0,19922.0,110503.2180492851,UNC13C
1432,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0061874168605085,0,0,19939.0,115499.24335773686,DGKB
1433,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0061874168605085,0,0,19903.0,106058.9096435903,DGKB
1434,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKB
1435,KEGG_2019_Human,Choline metabolism in cancer,1/99,0.0049499334884068,0.0061874168605085,0,0,19901.0,105642.09305076736,DGKB
1436,KEGG_2019_Human,Phospholipase D signaling pathway,1/148,0.007399915061391,0.007399915061391,0,0,19852.0,97399.60470052566,DGKB
1437,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,PLXNA2
1438,KEGG_2019_Human,Basal transcription factors,1/45,0.0022499601197094,0.0022499601197094,0,0,19955.0,121662.49782449217,TAF6L
1439,KEGG_2019_Human,Fanconi anemia pathway,1/54,0.0026999549628563,0.0026999549628563,0,0,19946.0,117971.01964061816,POLN
1440,KEGG_2019_Human,p53 signaling pathway,1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,CD82
1441,KEGG_2019_Human,Mismatch repair,1/23,0.0011499748819949,0.0023499589392381,0,0,19977.0,135204.63922267244,POLD2
1442,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0023499589392381,0,0,19967.0,127928.56031580272,POLD2
1443,KEGG_2019_Human,DNA replication,1/36,0.0017999657178272,0.0023499589392381,0,0,19964.0,126172.23364250171,POLD2
1444,KEGG_2019_Human,Homologous recombination,1/41,0.0020499625466866,0.0023499589392381,0,0,19959.0,123544.88783416104,POLD2
1445,KEGG_2019_Human,Nucleotide excision repair,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,POLD2
1446,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,RAB11FIP5
1447,KEGG_2019_Human,Nicotine addiction,1/40,0.0019999631680592,0.0079332111171108,0,0,19960.0,124043.94523066044,GRIN3B
1448,KEGG_2019_Human,Cocaine addiction,1/49,0.0024499577795033,0.0079332111171108,0,0,19951.0,119939.1172087114,GRIN3B
1449,KEGG_2019_Human,Amphetamine addiction,1/68,0.0033999476216189,0.0079332111171108,0,0,19932.0,113293.39338050144,GRIN3B
1450,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0099748729987182,0,0,19886.0,102756.96431429044,GRIN3B
1451,KEGG_2019_Human,Alcoholism,1/180,0.0089999047745351,0.0123665447530631,0,0,19820.0,93362.92821536642,GRIN3B
1452,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0123665447530631,0,0,19788.0,89974.27756224656,GRIN3B
1453,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRIN3B
1454,KEGG_2019_Human,alpha-Linolenic acid metabolism,1/25,0.0012499733663791,0.0020249578413544,0,0,19975.0,133525.54486996148,FADS2
1455,KEGG_2019_Human,Biosynthesis of unsaturated fatty acids,1/27,0.0013499718942362,0.0020249578413544,0,0,19973.0,131975.02298599784,FADS2
1456,KEGG_2019_Human,PPAR signaling pathway,1/74,0.0036999446830449,0.0036999446830449,0,0,19926.0,111574.38983110404,FADS2
1457,KEGG_2019_Human,Phototransduction,1/28,0.0013999711732997,0.0027999423465995,0,0,19972.0,131242.0761597353,GUCY2F
1458,KEGG_2019_Human,Purine metabolism,1/129,0.006449921761047,0.006449921761047,0,0,19871.0,100223.109907462,GUCY2F
1459,KEGG_2019_Human,Sphingolipid metabolism,1/47,0.0023499589392381,0.0023499589392381,0,0,19953.0,120782.64067395544,UGCG
1460,KEGG_2019_Human,Autoimmune thyroid disease,1/53,0.0026499555173137,0.0145586837375733,0,0,19947.0,118349.78824235698,IFNA5
1461,KEGG_2019_Human,Cytosolic DNA-sensing pathway,1/63,0.0031499501598827,0.0145586837375733,0,0,19937.0,114844.46974572667,IFNA5
1462,KEGG_2019_Human,RIG-I-like receptor signaling pathway,1/70,0.0034999466296654,0.0145586837375733,0,0,19930.0,112704.30065625212,IFNA5
1463,KEGG_2019_Human,Toll-like receptor signaling pathway,1/104,0.0051999314202997,0.0145586837375733,0,0,19896.0,104635.24941415618,IFNA5
1464,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,1/131,0.0065499210316603,0.0145586837375733,0,0,19869.0,99907.33811343512,IFNA5
1465,KEGG_2019_Human,Measles,1/138,0.0068999185254481,0.0145586837375733,0,0,19862.0,98838.19160389496,IFNA5
1466,KEGG_2019_Human,Hepatitis C,1/155,0.0077499127120574,0.0145586837375733,0,0,19845.0,96448.16254952336,IFNA5
1467,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA5
1468,KEGG_2019_Human,JAK-STAT signaling pathway,1/162,0.0080999104202618,0.0145586837375733,0,0,19838.0,95537.86936302872,IFNA5
1469,KEGG_2019_Human,Hepatitis B,1/163,0.0081499100978668,0.0145586837375733,0,0,19837.0,95410.9786681514,IFNA5
1470,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0145586837375733,0,0,19829.0,94422.42241345016,IFNA5
1471,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0145586837375733,0,0,19822.0,93593.82745769851,IFNA5
1472,KEGG_2019_Human,Tuberculosis,1/179,0.0089499050800561,0.0145586837375733,0,0,19821.0,93478.0629355712,IFNA5
1473,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.0145586837375733,0,0,19814.0,92684.96451050608,IFNA5
1474,KEGG_2019_Human,Epstein-Barr virus infection,1/201,0.0100498985877989,0.0145586837375733,0,0,19799.0,91079.21596609056,IFNA5
1475,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0145586837375733,0,0,19788.0,89974.27756224656,IFNA5
1476,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0145586837375733,0,0,19775.0,88738.27077557483,IFNA5
1477,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0179665141039676,0,0,19706.0,83157.67014793828,IFNA5
1478,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0191051096893273,0,0,19670.0,80733.60565076157,IFNA5
1479,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0194698489055035,0,0,19646.0,79255.8617626126,IFNA5
1480,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0257712598834163,0,0,19508.0,72277.44006442746,IFNA5
1481,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,IFNA5
1482,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,HERC1
1483,KEGG_2019_Human,RNA degradation,1/79,0.0039499423167337,0.0039499423167337,0,0,19921.0,110243.89578070649,TTC37
1484,KEGG_2019_Human,Autophagy,1/128,0.0063999221281459,0.0063999221281459,0,0,19872.0,100382.8010329652,SUPT20H
1485,KEGG_2019_Human,Renin-angiotensin system,1/23,0.0011499748819949,0.0011499748819949,0,0,19977.0,135204.63922267244,PREP
1486,KEGG_2019_Human,Pentose phosphate pathway,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,TKT
1487,KEGG_2019_Human,Axon guidance,1/181,0.0090499044707863,0.0090499044707863,0,0,19819.0,93248.41634586031,EPHB2
1488,KEGG_2019_Human,Fat digestion and absorption,1/41,0.0020499625466866,0.0030499512001654,0,0,19959.0,123544.88783416104,MOGAT2
1489,KEGG_2019_Human,Glycerolipid metabolism,1/61,0.0030499512001654,0.0030499512001654,0,0,19939.0,115499.24335773686,MOGAT2
1490,KEGG_2019_Human,Progesterone-mediated oocyte maturation,1/99,0.0049499334884068,0.0085623985997064,0,0,19901.0,105642.09305076736,ANAPC1
1491,KEGG_2019_Human,Cell cycle,1/124,0.0061999236097501,0.0085623985997064,0,0,19876.0,101034.04709010696,ANAPC1
1492,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0085623985997064,0,0,19875.0,100869.32368441945,ANAPC1
1493,KEGG_2019_Human,Ubiquitin mediated proteolysis,1/137,0.0068499188797651,0.0085623985997064,0,0,19863.0,98987.62735269018,ANAPC1
1494,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,1/219,0.0109498935894162,0.0109498935894162,0,0,19781.0,89299.85161916987,ANAPC1
1495,KEGG_2019_Human,Lysosome,1/123,0.0061499239842961,0.0121998870519305,0,0,19877.0,101200.07933676826,IGF2R
1496,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,IGF2R
1497,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0097998678162159,0,0,19935.0,114209.92613860144,CACNA1H
1498,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0097998678162159,0,0,19903.0,106058.9096435903,CACNA1H
1499,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0097998678162159,0,0,19902.0,105849.45495286948,CACNA1H
1500,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.011279882844162,0,0,19845.0,96448.16254952336,CACNA1H
1501,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.011279882844162,0,0,19812.0,92463.712994847,CACNA1H
1502,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA1H
1503,KEGG_2019_Human,Lysine degradation,1/59,0.0029499522555206,0.0029499522555206,0,0,19941.0,116175.59385530632,KMT2B
1504,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF157
1505,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,DHX38
1506,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0035999456502131,0,0,19928.0,112131.59838572376,ACTN3
1507,KEGG_2019_Human,Glutathione metabolism,1/56,0.0027999538675741,0.0027999538675741,0,0,19944.0,117233.87022514464,OPLAH
1508,KEGG_2019_Human,ECM-receptor interaction,1/82,0.004099940929819,0.016399763719276,0,0,19918.0,109484.9180722932,RELN
1509,KEGG_2019_Human,Focal adhesion,1/199,0.0099498991610159,0.0176998626413668,0,0,19801.0,91286.4288690606,RELN
1510,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0176998626413668,0,0,19670.0,80733.60565076157,RELN
1511,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0176998626413668,0,0,19646.0,79255.8617626126,RELN
1512,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0109665527651575,0,0,19910.0,107587.50385474482,ADRA1A
1513,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0109665527651575,0,0,19880.0,101706.2448082016,ADRA1A
1514,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0109665527651575,0,0,19868.0,99751.22090491928,ADRA1A
1515,KEGG_2019_Human,Adrenergic signaling in cardiomyocytes,1/145,0.0072499160871101,0.0109665527651575,0,0,19855.0,97820.92670675044,ADRA1A
1516,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0109665527651575,0,0,19834.0,95034.82345515196,ADRA1A
1517,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0109665527651575,0,0,19812.0,92463.712994847,ADRA1A
1518,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,ADRA1A
1519,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0085998782347732,0,0,19914.0,108514.46102290176,GPR119
1520,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0105998955026255,0,0,19788.0,89974.27756224656,GPR119
1521,KEGG_2019_Human,Spliceosome,1/134,0.0066999199497742,0.0066999199497742,0,0,19866.0,99442.43560916925,PLRG1
1522,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,CDIPT
1523,KEGG_2019_Human,Glycerophospholipid metabolism,1/97,0.0048499343304706,0.0049499334884068,0,0,19903.0,106058.9096435903,CDIPT
1524,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,CDIPT
1525,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,ARHGEF18
1526,KEGG_2019_Human,Glycosaminoglycan degradation,1/19,0.00094997806231055,0.00094997806231055,0,0,19981.0,139049.2109571672,HYAL3
1527,KEGG_2019_Human,Regulation of actin cytoskeleton,1/214,0.0106998949514067,0.0106998949514067,0,0,19786.0,89779.39753374986,ITGAD
1528,KEGG_2019_Human,Endocrine and other factor-regulated calcium reabsorption,1/48,0.0023999583567988,0.0071998750703964,0,0,19952.0,120356.5272753826,PTH1R
1529,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0079498959114788,0,0,19894.0,104245.78450366124,PTH1R
1530,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,PTH1R
1531,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0102998636605234,0,0,19897.0,104832.7525292024,GCGR
1532,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GCGR
1533,KEGG_2019_Human,Adipocytokine signaling pathway,1/69,0.003449947123837,0.0074499147221605,0,0,19931.0,112996.7391397682,ADIPOR1
1534,KEGG_2019_Human,Longevity regulating pathway,1/102,0.0050999322416682,0.0074499147221605,0,0,19898.0,105032.15064717118,ADIPOR1
1535,KEGG_2019_Human,AMPK signaling pathway,1/120,0.0059999251180858,0.0074499147221605,0,0,19880.0,101706.2448082016,ADIPOR1
1536,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0074499147221605,0,0,19851.0,97261.02051561224,ADIPOR1
1537,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0141331940035007,0,0,19847.0,96715.6407630817,OXTR
1538,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0141331940035007,0,0,19812.0,92463.712994847,OXTR
1539,KEGG_2019_Human,cAMP signaling pathway,1/212,0.0105998955026255,0.0141331940035007,0,0,19788.0,89974.27756224656,OXTR
1540,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,OXTR
1541,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0083999085011095,0,0,19832.0,94787.72752807094,BRD7
1542,KEGG_2019_Human,Oxidative phosphorylation,1/133,0.0066499203093911,0.0112582177134695,0,0,19867.0,99596.2591544721,NDUFB4
1543,KEGG_2019_Human,Parkinson disease,1/142,0.0070999171242726,0.0112582177134695,0,0,19858.0,98250.87390500787,NDUFB4
1544,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0112582177134695,0,0,19852.0,97399.60470052566,NDUFB4
1545,KEGG_2019_Human,Non-alcoholic fatty liver disease (NAFLD),1/149,0.0074499147221605,0.0112582177134695,0,0,19851.0,97261.02051561224,NDUFB4
1546,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0112582177134695,0,0,19829.0,94422.42241345016,NDUFB4
1547,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0112582177134695,0,0,19807.0,91920.47679471428,NDUFB4
1548,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0115498903940656,0,0,19769.0,88191.07730937863,NDUFB4
1549,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,PPP5D1
1550,KEGG_2019_Human,Thyroid cancer,1/37,0.0018499650702878,0.0095198963012574,0,0,19963.0,125618.9446446357,TCF7
1551,KEGG_2019_Human,Endometrial cancer,1/58,0.0028999527887707,0.0095198963012574,0,0,19942.0,116522.31890946148,TCF7
1552,KEGG_2019_Human,Basal cell carcinoma,1/63,0.0031499501598827,0.0095198963012574,0,0,19937.0,114844.46974572667,TCF7
1553,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0095198963012574,0,0,19934.0,113899.85357353876,TCF7
1554,KEGG_2019_Human,Adherens junction,1/72,0.0035999456502131,0.0095198963012574,0,0,19928.0,112131.59838572376,TCF7
1555,KEGG_2019_Human,Arrhythmogenic right ventricular cardiomyopathy (ARVC),1/72,0.0035999456502131,0.0095198963012574,0,0,19928.0,112131.59838572376,TCF7
1556,KEGG_2019_Human,Colorectal cancer,1/86,0.0042999391173866,0.0095198963012574,0,0,19914.0,108514.46102290176,TCF7
1557,KEGG_2019_Human,Prostate cancer,1/97,0.0048499343304706,0.0095198963012574,0,0,19903.0,106058.9096435903,TCF7
1558,KEGG_2019_Human,Melanogenesis,1/101,0.0050499326546803,0.0095198963012574,0,0,19899.0,105233.48101229242,TCF7
1559,KEGG_2019_Human,Breast cancer,1/147,0.0073499154017982,0.0095198963012574,0,0,19853.0,97539.10874372096,TCF7
1560,KEGG_2019_Human,Gastric cancer,1/149,0.0074499147221605,0.0095198963012574,0,0,19851.0,97261.02051561224,TCF7
1561,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0095198963012574,0,0,19845.0,96448.16254952336,TCF7
1562,KEGG_2019_Human,Wnt signaling pathway,1/158,0.0078999117225733,0.0095198963012574,0,0,19842.0,96053.2110949472,TCF7
1563,KEGG_2019_Human,Hippo signaling pathway,1/160,0.0079999110688441,0.0095198963012574,0,0,19840.0,95793.96509856998,TCF7
1564,KEGG_2019_Human,Hepatocellular carcinoma,1/168,0.0083999085011095,0.0095198963012574,0,0,19832.0,94787.72752807094,TCF7
1565,KEGG_2019_Human,Human papillomavirus infection,1/330,0.0164998674589645,0.0175311091751498,0,0,19670.0,80733.60565076157,TCF7
1566,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,TCF7
1567,KEGG_2019_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,CS
1568,KEGG_2019_Human,Citrate cycle (TCA cycle),1/30,0.0014999697593334,0.0014999697593334,0,0,19970.0,129851.13732048514,CS
1569,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0168998658265596,0,0,19812.0,92463.712994847,GRPR
1570,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GRPR
1571,KEGG_2019_Human,Cholesterol metabolism,1/50,0.0024999572069037,0.0024999572069037,0,0,19950.0,119530.05920663515,LPA
1572,KEGG_2019_Human,Inositol phosphate metabolism,1/74,0.0036999446830449,0.0049499334884068,0,0,19926.0,111574.38983110404,PI4KA
1573,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0049499334884068,0,0,19901.0,105642.09305076736,PI4KA
1574,KEGG_2019_Human,mRNA surveillance pathway,1/91,0.0045499369072032,0.0045499369072032,0,0,19909.0,107362.10783923086,SSU72
1575,KEGG_2019_Human,Synthesis and degradation of ketone bodies,1/10,0.0004999862257578379,0.0019999449030313,0,0,19990.0,151942.5908680334,HMGCLL1
1576,KEGG_2019_Human,Butanoate metabolism,1/28,0.0013999711732997,0.0027999423465995,0,0,19972.0,131242.0761597353,HMGCLL1
1577,KEGG_2019_Human,"Valine, leucine and isoleucine degradation",1/48,0.0023999583567988,0.0031999444757317,0,0,19952.0,120356.5272753826,HMGCLL1
1578,KEGG_2019_Human,Peroxisome,1/83,0.0041499404726918,0.0041499404726918,0,0,19917.0,109237.99888847338,HMGCLL1
1579,KEGG_2019_Human,Endocytosis,1/244,0.0121998870519305,0.0121998870519305,0,0,19756.0,87051.4275316661,PSD4
1580,KEGG_2019_Human,Base excision repair,1/33,0.0016499677032113,0.0049499031096341,0,0,19967.0,127928.56031580272,PARP3
1581,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0080999104202618,0,0,19857.0,98106.57763600958,PARP3
1582,KEGG_2019_Human,Necroptosis,1/162,0.0080999104202618,0.0080999104202618,0,0,19838.0,95537.86936302872,PARP3
1583,KEGG_2019_Human,"Phenylalanine, tyrosine and tryptophan biosynthesis",1/5,0.0002499917995416556,0.0017499425967915,0,0,19995.0,165840.17843725558,GOT1
1584,KEGG_2019_Human,Phenylalanine metabolism,1/17,0.0008499797390404818,0.0024499450395929,0,0,19983.0,141285.76583697114,GOT1
1585,KEGG_2019_Human,Arginine biosynthesis,1/21,0.0010499764455398,0.0024499450395929,0,0,19979.0,137035.71221916509,GOT1
1586,KEGG_2019_Human,"Alanine, aspartate and glutamate metabolism",1/35,0.0017499663721595,0.0024499577795033,0,0,19965.0,126740.98858805298,GOT1
1587,KEGG_2019_Human,Tyrosine metabolism,1/36,0.0017999657178272,0.0024499577795033,0,0,19964.0,126172.23364250171,GOT1
1588,KEGG_2019_Human,Cysteine and methionine metabolism,1/47,0.0023499589392381,0.0024499577795033,0,0,19953.0,120782.64067395544,GOT1
1589,KEGG_2019_Human,Arginine and proline metabolism,1/49,0.0024499577795033,0.0024499577795033,0,0,19951.0,119939.1172087114,GOT1
1590,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0068499188797651,0,0,19863.0,98987.62735269018,KRT40
1591,KEGG_2019_Human,Long-term depression,1/60,0.002999951725986,0.0099295756623236,0,0,19940.0,115834.63209072244,ITPR3
1592,KEGG_2019_Human,Cortisol synthesis and secretion,1/65,0.003249949134407,0.0099295756623236,0,0,19935.0,114209.92613860144,ITPR3
1593,KEGG_2019_Human,Long-term potentiation,1/67,0.0033499481224912,0.0099295756623236,0,0,19933.0,113594.38808369274,ITPR3
1594,KEGG_2019_Human,Renin secretion,1/69,0.003449947123837,0.0099295756623236,0,0,19931.0,112996.7391397682,ITPR3
1595,KEGG_2019_Human,Thyroid hormone synthesis,1/74,0.0036999446830449,0.0099295756623236,0,0,19926.0,111574.38983110404,ITPR3
1596,KEGG_2019_Human,Gastric acid secretion,1/75,0.0037499442041125,0.0099295756623236,0,0,19925.0,111301.33528642564,ITPR3
1597,KEGG_2019_Human,Taste transduction,1/83,0.0041499404726918,0.0099295756623236,0,0,19917.0,109237.99888847338,ITPR3
1598,KEGG_2019_Human,Insulin secretion,1/86,0.0042999391173866,0.0099295756623236,0,0,19914.0,108514.46102290176,ITPR3
1599,KEGG_2019_Human,Gap junction,1/88,0.0043999382262822,0.0099295756623236,0,0,19912.0,108045.79305232369,ITPR3
1600,KEGG_2019_Human,Salivary secretion,1/90,0.0044999373439762,0.0099295756623236,0,0,19910.0,107587.50385474482,ITPR3
1601,KEGG_2019_Human,GnRH signaling pathway,1/93,0.0046499360391879,0.0099295756623236,0,0,19907.0,106918.54242106884,ITPR3
1602,KEGG_2019_Human,Circadian entrainment,1/97,0.0048499343304706,0.0099295756623236,0,0,19903.0,106058.9096435903,ITPR3
1603,KEGG_2019_Human,Pancreatic secretion,1/98,0.0048999339081079,0.0099295756623236,0,0,19902.0,105849.45495286948,ITPR3
1604,KEGG_2019_Human,Aldosterone synthesis and secretion,1/98,0.0048999339081079,0.0099295756623236,0,0,19902.0,105849.45495286948,ITPR3
1605,KEGG_2019_Human,Phosphatidylinositol signaling system,1/99,0.0049499334884068,0.0099295756623236,0,0,19901.0,105642.09305076736,ITPR3
1606,KEGG_2019_Human,Inflammatory mediator regulation of TRP channels,1/100,0.0049999330710556,0.0099295756623236,0,0,19900.0,105436.78197328727,ITPR3
1607,KEGG_2019_Human,Glucagon signaling pathway,1/103,0.0051499318302617,0.0099295756623236,0,0,19897.0,104832.7525292024,ITPR3
1608,KEGG_2019_Human,C-type lectin receptor signaling pathway,1/104,0.0051999314202997,0.0099295756623236,0,0,19896.0,104635.24941415618,ITPR3
1609,KEGG_2019_Human,"Parathyroid hormone synthesis, secretion and action",1/106,0.0052999306076525,0.0099295756623236,0,0,19894.0,104245.78450366124,ITPR3
1610,KEGG_2019_Human,Cholinergic synapse,1/112,0.0055999282120529,0.0099295756623236,0,0,19888.0,103119.30984392198,ITPR3
1611,KEGG_2019_Human,Serotonergic synapse,1/113,0.0056499278191151,0.0099295756623236,0,0,19887.0,102937.34947211576,ITPR3
1612,KEGG_2019_Human,Glutamatergic synapse,1/114,0.005699927427839,0.0099295756623236,0,0,19886.0,102756.96431429044,ITPR3
1613,KEGG_2019_Human,Platelet activation,1/124,0.0061999236097501,0.0099295756623236,0,0,19876.0,101034.04709010696,ITPR3
1614,KEGG_2019_Human,Oocyte meiosis,1/125,0.0062499232373748,0.0099295756623236,0,0,19875.0,100869.32368441945,ITPR3
1615,KEGG_2019_Human,Dopaminergic synapse,1/131,0.0065499210316603,0.0099295756623236,0,0,19869.0,99907.33811343512,ITPR3
1616,KEGG_2019_Human,Vascular smooth muscle contraction,1/132,0.0065999206698993,0.0099295756623236,0,0,19868.0,99751.22090491928,ITPR3
1617,KEGG_2019_Human,Estrogen signaling pathway,1/137,0.0068499188797651,0.0099295756623236,0,0,19863.0,98987.62735269018,ITPR3
1618,KEGG_2019_Human,Apelin signaling pathway,1/137,0.0068499188797651,0.0099295756623236,0,0,19863.0,98987.62735269018,ITPR3
1619,KEGG_2019_Human,Apoptosis,1/143,0.0071499167770442,0.0099295756623236,0,0,19857.0,98106.57763600958,ITPR3
1620,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0099295756623236,0,0,19852.0,97399.60470052566,ITPR3
1621,KEGG_2019_Human,Oxytocin signaling pathway,1/153,0.0076499133771537,0.0099295756623236,0,0,19847.0,96715.6407630817,ITPR3
1622,KEGG_2019_Human,Cushing syndrome,1/155,0.0077499127120574,0.0099295756623236,0,0,19845.0,96448.16254952336,ITPR3
1623,KEGG_2019_Human,Cellular senescence,1/160,0.0079999110688441,0.00993928344917,0,0,19840.0,95793.96509856998,ITPR3
1624,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.0082999091363732,0.0100087139585677,0,0,19834.0,95034.82345515196,ITPR3
1625,KEGG_2019_Human,Alzheimer disease,1/171,0.0085499075557634,0.0100156059938943,0,0,19829.0,94422.42241345016,ITPR3
1626,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.0088999053857096,0.0101360033559471,0,0,19822.0,93593.82745769851,ITPR3
1627,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,1/186,0.0092999029651357,0.010141999925672,0,0,19814.0,92684.96451050608,ITPR3
1628,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.010141999925672,0,0,19812.0,92463.712994847,ITPR3
1629,KEGG_2019_Human,Proteoglycans in cancer,1/201,0.0100498985877989,0.0105652780025579,0,0,19799.0,91079.21596609056,ITPR3
1630,KEGG_2019_Human,Human immunodeficiency virus 1 infection,1/212,0.0105998955026255,0.0108648928901912,0,0,19788.0,89974.27756224656,ITPR3
1631,KEGG_2019_Human,Human cytomegalovirus infection,1/225,0.0112498919790339,0.0112498919790339,0,0,19775.0,88738.27077557483,ITPR3
1632,KEGG_2019_Human,Retrograde endocannabinoid signaling,1/148,0.007399915061391,0.0153998538587541,0,0,19852.0,97399.60470052566,CNR1
1633,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0153998538587541,0,0,19794.0,90569.849337325,CNR1
1634,KEGG_2019_Human,Thermogenesis,1/231,0.0115498903940656,0.0153998538587541,0,0,19769.0,88191.07730937863,CNR1
1635,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,CNR1
1636,KEGG_2019_Human,Huntington disease,1/193,0.0096499008972596,0.0096499008972596,0,0,19807.0,91920.47679471428,DNAH1
1637,KEGG_2019_Human,Tight junction,1/170,0.0084999078692823,0.0084999078692823,0,0,19830.0,94543.49009679438,MYH3
1638,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.0168998658265596,0.0168998658265596,0,0,19662.0,80229.79996326564,GLP2R
1639,KEGG_2019_Human,Acute myeloid leukemia,1/66,0.003299948626608,0.0184373436920633,0,0,19934.0,113899.85357353876,CSF1R
1640,KEGG_2019_Human,Hematopoietic cell lineage,1/97,0.0048499343304706,0.0184373436920633,0,0,19903.0,106058.9096435903,CSF1R
1641,KEGG_2019_Human,Osteoclast differentiation,1/127,0.0063499224962247,0.0184373436920633,0,0,19873.0,100543.72072014232,CSF1R
1642,KEGG_2019_Human,Transcriptional misregulation in cancer,1/186,0.0092999029651357,0.0184373436920633,0,0,19814.0,92684.96451050608,CSF1R
1643,KEGG_2019_Human,Rap1 signaling pathway,1/206,0.010299897173561,0.0184373436920633,0,0,19794.0,90569.849337325,CSF1R
1644,KEGG_2019_Human,Ras signaling pathway,1/232,0.0115998901349604,0.0184373436920633,0,0,19768.0,88101.22480150245,CSF1R
1645,KEGG_2019_Human,Cytokine-cytokine receptor interaction,1/294,0.0146998751759735,0.0184373436920633,0,0,19706.0,83157.67014793828,CSF1R
1646,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0184373436920633,0,0,19705.0,83086.53988020132,CSF1R
1647,KEGG_2019_Human,PI3K-Akt signaling pathway,1/354,0.0176998626413668,0.0196665140459632,0,0,19646.0,79255.8617626126,CSF1R
1648,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,CSF1R
1649,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.0245998389796247,0.0245998389796247,0,0,19508.0,72277.44006442746,ZNF184
1650,KEGG_2019_Human,RNA transport,1/165,0.0082499094553477,0.0085499075557634,0,0,19835.0,95159.46482222488,NUP98
1651,KEGG_2019_Human,Influenza A,1/171,0.0085499075557634,0.0085499075557634,0,0,19829.0,94422.42241345016,NUP98
1652,KEGG_2019_Human,Drug metabolism,1/108,0.0053999298011749,0.0053999298011749,0,0,19892.0,103863.47861844616,CES2
1653,KEGG_2019_Human,Type II diabetes mellitus,1/46,0.0022999595269283,0.0068998785807849,0,0,19954.0,121217.8313311442,CACNA1E
1654,KEGG_2019_Human,Calcium signaling pathway,1/188,0.009399902370135,0.0140998535552025,0,0,19812.0,92463.712994847,CACNA1E
1655,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,CACNA1E
1656,KEGG_2019_Human,Aminoacyl-tRNA biosynthesis,1/66,0.003299948626608,0.003299948626608,0,0,19934.0,113899.85357353876,AARS2
1657,KEGG_2019_Human,Non-small cell lung cancer,1/66,0.003299948626608,0.006599897253216,0,0,19934.0,113899.85357353876,EML4
1658,KEGG_2019_Human,Pathways in cancer,1/530,0.0264998334376226,0.0264998334376226,0,0,19470.0,70688.10970701616,EML4
1659,KEGG_2019_Human,MAPK signaling pathway,1/295,0.0147498749536506,0.0147498749536506,0,0,19705.0,83086.53988020132,MAP4K4
